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Introduction 
Andrea Nardelli  7
GENERAL INTRODUCTION 
Adverse reactions to fragrances include allergic contact dermatitis (ACD), irritant contact dermatitis 
(ICD), photosensitivity, immediate contact reactions (contact urticaria), pigmented contact 
dermatitis, and also (worsening of) respiratory problems (de Groot, 2001). Contact allergy to 
fragrances, being a delayed hypersensitivity response that may clinically result in ACD is a 
common finding. It is due to a combination of repeated environmental exposure and age-related 
susceptibility factors (Buckley et al, 2003) and is commonly observed in patch-test populations, 
particularly, since allergenic fragrance chemicals are ubiquitous in our environment, not only in fine 
fragrances but also in a wide range of cosmetic, household and industrial products (Matura et al, 
2003). Actually, together with preservative agents, they are the most important sensitizing culprits 
in cosmetic products (Goossens, 2006-Schnuch et al, 2004). In this introductory chapter we will 
shortly review the chemistry, characteristics and the potential to induce adverse reactions. 
 
I. GENERAL ASPECTS ON FRAGRANCES 
1.1. Fragrance chemicals 
Perfumers have been creating fragrances for approximately 3.000 years. Over the centuries the role 
of fragrance in society has gained in importance, aiming to improve the quality of life by 
underlining the personality, attractiveness and well-being of its bearers. Today, the occupation as a 
perfumer is a well-established, but rather rare profession. The prerequisites for this profession 
include skills, such as memory for odors and their characteristics, as well as an artistic talent 
(Harder, 1998). 
A perfume is a blend of odorous ingredients composed of a diluent, usually ethanol, and a mixture 
of 10 to 300 different fragrance ingredients. Most fragrance chemicals are volatile aliphatic or 
aromatic molecules that can be categorized according to their functional groups, including 
aldehydes, alcohols, ketones, acids, esters, ethers, terpenes, etc. The most volatile ingredients are 
called “top notes” (citrus, green-leafy, herbaceous, fruity and spicy). The most essential part of the 
perfume is formed by the “bouquet” or “heart note” built up by floral accords. The long-lasting 
materials are known as “bottom” or “dry-down” notes and include woody, moss-like and sweet 
vanilla-like ingredients together with animal elements, mostly of musky character. Approximately 
3000 different fragrance chemicals are currently used in the perfume industry and are often 
combined to create characteristic scents (Ford, 1991). 
 
1.2. Exposure 
Perfumes and virtually all cosmetics and toiletries such as deodorants, aftershaves, skin care 
products, lipsticks, powders, shampoos and soaps contain fragrance chemicals. In addition, they are 
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present in various household products such as fabric softeners, detergents, cleansing agents, 
polishes and air fresheners, as well as in industrial products such as soluble oils and degreasers. 
Moreover, several products or materials such as cars, candles, toys, and various branded articles 
may be perfume scented. 
Fragrance chemicals may come in contact with the skin, eyes, or respiratory organs. 
With regard to skin contact, any part of the body is exposed, i.e. scalp: shampoo, hair lacquer, hair 
gel; face: skin care products, aftershave, perfumed tissue handkerchiefs, airborne from perfumes on 
clothing; the eyelids: eye cosmetics; the lips: lipstick, toothpaste; the neck: aftershave, perfume; the 
trunk: body-care products; the axillae: deodorants; the perianal area: fragranced (moistened) toilet 
tissues or wipes; the vulvar area: feminine hygiene sprays, sanitary napkins, topical drugs; the 
hands: moisturizing creams, soaps, and, in fact, any scented product; the feet: antiperspirants or skin 
care products. 
The contact may be intentional, e.g. by direct contact with perfumed cosmetics and medications, or 
unintentionally, by evaporation from consumer products or from other persons wearing perfume. 
Moreover, fragrances also occur in an occupational environment, i.e. workers in the cosmetics 
industry, such as beauticians, hairdressers, and aroma therapists, housewives, health-care, and 
cleaning personnel, as well as in industrial settings. Thus, it can be stated that fragrance materials 
are ubiquitous and it is estimated that 95% of the female population and at least 75% of the male 
population come into daily contact with cosmetic products (Fisher, 1980-Nielsen et al, 1993). 
 
1.3. Adverse effects from fragrances 
The ubiquitous presence of fragrances in modern society coupled with the increased usage of 
fragrance-containing products by people of raising economic power (Lunder et al, 2000), as well as 
higher interest in 'all natural' products, which sometimes contain fragrance sensitizers in high 
enough concentrations to induce sensitization (Somogyi, 1996), all contribute to the increase in 
adverse effects observed. They may be categorized according to localization (i.e. the skin or 
respiratory organs) or pathophysiology (i.e. type of immunological response) (Rastogi et al, 1996-
de Groot et al, 1997-Eriksson et al, 1987). 
 
1.3.1 Respiratory and other mucosal symptoms 
 
The adverse effects of fragrance chemicals related to the respiratory organs have not been well 
described and the underlying pathophysiology of the symptoms is unclear. In a single case, 
anaphylaxis has been reported after spraying perfume in the eyes (Lessenger, 2001), which could 
indicate mechanisms associated with IgE-mediated allergy. Studies in selected groups of patients 
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with lower respiratory symptoms have shown that both inhalation and exposure of only the eyes to 
vapors of perfume may elicit lower respiratory symptoms, in addition to eye symptoms (Eriksson et 
al, 1987). 
A decline in lung function after perfume inhalation has been reported in individuals with severe 
asthma (Jensen et al, 1991), which has also been observed in subjects with occupational perfume 
exposure (Millqvist et al, 1996-Millqvist et al 2001-Schnuch et al 2002-Frosch et al, 2002-Baur et 
al, 1999). It has, however, been disputed whether all the respiratory symptoms elicited by fragrance 
products in persons with asthma can be attributed to bronchial obstruction (Millqvist et al, 1998). 
Moreover, lower respiratory symptoms associated with them are also frequent among non-asthmatic 
and non-allergic individuals (Kumar et al, 1995). The mechanisms involved could be similar to 
those observed with inhalation of capsaicin (the pungent principle in hot chili pepper), an 
experimentally used material to evaluate respiratory response, which stimulates the afferent C-fibres 
and Aδ-, fibres in the airways (Belvisi, 2003), and triggers the cough reflex in a dose-dependent 
way in normal individuals (Midgren et al, 1992). 
Elberling et al. (2005a- Elberling et al, 2005b-Elberling et al, 2004ab, Elberling et al, 2006) 
concluded that the association between eye and airway symptoms elicited by airborne chemicals 
may represent a syndrome, which is related to allergic contact dermatitis and perhaps hand eczema, 
but not to IgE-mediated allergy to proteins. Moreover, although psychological factors play a 
significant role in reporting symptoms elicited by airborne chemicals, both endogenous and 
environmental factors may be of greater importance for the induction and elicitation. 
In more recent studies, Schnuch et. al (2010) have shown that the lung function as expressed by 
forced expiratory volume in 1s (FEV1) did not change after any fragrance exposure. However, 
inhalation of fragrance compounds in high concentrations resulted in systemic (haematogenic) 
allergic contact dermatitis (flare) and increased skin symptom scores 24 and 72h following 
exposure in single patients allergic to ‘the’ fragrance. They concluded that inhalation of higher 
doses of potent contact allergens should be avoided by subjects specifically sensitized to these 
allergens. 
 
1.3.2. Dermatological problems 
Fragrance components can cause a number of local (and systemic) reactions. The following 
are the most common: 
- Contact dermatitis- allergic and irritant 
- Photosensitivity- allergic and toxic 
- Urticaria, both immunological and non-immunological 
- Pigmentation and depigmentation 
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The most common skin reaction seen by dermatologists to fragrance materials is allergic 
contact dermatitis. Most clinical pictures concern erythematous lesions at the contact site, but some 
cases may resemble nummular eczema, seborrhoeic or atopic dermatitis (especially in the skin 
folds), sycosis barbae, or lupus erythematosus (Meynadier et al, 1986). More acute lesions with 
papules, vesicles and oozing may sometimes be observed as well. With regard to the localization of 
the lesions, it can be expected that the neck, the skin behind the ear and the axillae are often 
implicated, given that they are exposed to products with high concentrations of fragrances 
(perfume, deodorant). Moreover, the sensitive skin of the face and eyelids is particularly susceptible 
to develop ACD from fragranced skin-care products, decorative cosmetics and cleansing 
preparations, and also from airborne exposure (Dooms-Goossens, 1993a-b); in man micro-traumata 
from shaving may facilitate skin penetration, thus contact and also photo-contact sensitization, the 
latter in combination with U.V. exposure. Moreover, also hand eczema is common in fragrance-
sensitive patients (Edman et al, 1994, Johansen et al, 1996, Heydorn et al, 2003 a-b); usually, they 
first develop irritant dermatitis or atopic dermatitis, which is later complicated by contact allergy to 
products used for treatment (fragranced topical drugs) or prevention (hand creams and lotions), or 
to other perfumed products contacted in the household, hobby, or work environment. Dyshidrotic 
eruptions on the hands have been attributed to ingestion of spices (Meynadier et al, 1986). Besides 
atopy, other existing eczematous conditions, located in the perianal or vulvar area (Nardelli et al, 
2004) may be complicated by fragrance allergy, and even facial psoriasis may be induced/ 
aggravated by ACD from fragrances (de Groot et al, 1983). 
Regarding photo-allergic dermatitis, during the 1980s numerous cases were reported due to musk 
ambrette (Raugi et al, 1979) and 6- methyl coumarin (Jackson et al, 1980), the former primarily 
observed in men due to after shave lotions, the latter associated with high concentrations used in a 
certain fragranced sunscreen. Both of these chemicals were removed from the market, hence such 
reactions have not been observed since. 
In this context we will focus on ACD. 
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Chapter 2 
 
Contact Allergy and the main fragrance allergens 
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II. CONTACT ALLERGY AND ALLERGIC CONTACT DERMATITIS 
 
The frequency of contact allergy to perfumes is estimated to be 1%-2% in the general population 
(1.1 % Denmark, 1.8% Norway) (Nielsen et al, 1992-Dotterud et al, 2007), and roughly 8% in 
contact eczema patients (de Groot, 2001-Buckley et al, 2003-Mortz et al, 2013). Of course, not all 
patient with contact allergy do actually suffer from allergic contact dermatitis (ACD). 
 
2.1 Mechanism of allergic contact dermatitis 
 
Allergic contact dermatitis (ACD) is the clinical manifestation of contact allergy, a delayed-type 
hypersensitivity (type IV immunological reaction) (Rustemeyer et al, 2001). The immune response 
in ACD is divided in two steps: Sensitization Phase also called afferent or induction phase. This 
step lasts 8 to 15 days in humans and generally has no clinical consequences. On the other side the 
Effectors Phase or Elicitation Phase is produced within 3 days with clinical manifestations of an 
inflammatory reaction, i.e. eczema, which persists over several days and progressively decreases 
upon physiological down-regulatory mechanisms (Figure 1). The innate immune mechanisms and 
the skin immune systems involved in contact dermatitis will not be discussed in detail in this 
manuscript; only the concepts of haptens, “pre- and pro-haptens” will be mentioned because some 
fragrance allergens behave as the latter. 
 
 
 
Figure 1 
Lymphocyte-mediated immune mechanisms in contact allergy. Sensitization phase (a). The contact allergen activates 
dendritic cells in the skin via ‘pattern recognition receptors’ such as TLRs. Subsequently naïve T helper (Th) cells are 
polarized upon specific recognition of the haptenated allergen by the major histocompatibility complex (MHC), co-
stimulatory signals and cytokines such as IL-12, IL-4, IL-1β and IL-6. Elicitation phase (b). Hapten-specific cytotoxic 
CD8+ T lymphocytes (CTLs) release inflammatory cytokines and induce disease-specific local skin lesions following 
re-exposure of the skin to the same contact allergen (Peiser et al, 2012) (reprinted with permission by Springer). 
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2.1.1 Haptens, pro- and prehaptens 
Contact allergy caused by low molecular weight compounds (so-called haptens) requires the 
formation of antigenic hapten-protein complexes. The potential of a low molecular weight 
compound to become an allergen is determined by its ability to penetrate the skin, to react with skin 
proteins, and its processing and presentation by dendritic cells to memory T-lymphocytes. Some 
compounds will react directly (e.g. nickel), while others require activation, either externally or 
metabolically inside the skin (Karlberg et al, 2008). Prehaptens are compounds with no or low 
sensitizing potential that are activated externally, while prohaptens have been defined as non-
sensitizing compounds that require metabolic activation (Lepoittevin, 2006). 
Examples of prehaptens are found among the unsaturated hydrocarbons and ethers such as common 
fragrance terpenes, diterpenes in colophonium and ethoxylated surfactants. Patch tests revealed 
some of these substances to be potent skin sensitizers following their activation by autoxidation. For 
example, whereas limonene and linalool, two frequently used fragrance components, rarely cause 
sensitization by themselves (Christensson et al, 2010-Matura et al, 2002-2005-Brared Christensson 
et al, 2009-2012-Schnuch et al, 2007), autoxidation results in the formation of the corresponding 
hydroperoxides (Skold et al, 2008), for which multicentre studies have shown that they are among 
the most common causes for ACD (see below). 
With regard to prohaptens, their activation could vary depending on the individuals’ enzymatic 
expression patterns. Well-known examples of prohaptens are cinnamyl alcohol (3-phenyl-2-propen-
1-ol) and urushiols (Kalergis et al, 1997-Elahi et al, 2004). 
Some compounds act both as prehaptens and prohaptens and, depending on the way of activation, 
the resulting haptens can have a different skin sensitization potential. Well-studied examples are 
cinnamyl alcohol (see below) and the moderate sensitizer geraniol, which is present in fragrance 
mix (I) in the baseline series for the diagnosis of contact allergy. Studies showed geraniol to act as a 
prehapten and prohapten activated by cytochrome P450-dependent mono-oxygenases (CYPs), both 
leading to the formation of geranial and neral; beside, enzymatic activation also produces 
sensitizing epoxides (6,7-epoxygeraniol and 6,7-epoxigeranial), while autoxidation results in the 
formation of sensitizing hydroperoxides (Hagvall et al, 2007-2008-2012). 
Considering the importance of oxidation for the formation of haptens, autoxidation and CYP-
mediated metabolism should be part of the hazard identification for potential contact allergens. This 
can be achieved by predicting autoxidation using structure activity relationships (SAR) and by in-
vitro CYP activity assays. A recently developed CYP cocktail is based on cutaneous CYP enzymes 
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and thus allows studying part of the skin metabolism in vitro (Peiser et al, 2012). Furthermore, 
diagnosis of contact allergens should include patch tests with oxidized forms of the corresponding 
substances. 
 
2.2 Fragrances as complex mixtures of molecules 
Sensitization to even a simple mixture of molecules with very different physicochemical 
properties results in many interactions during skin penetration, metabolism and epitope formation 
by reaction with the nucleophilic residues of proteins. Not all mixes are the same; two main 
categories can be distinguished (Dupuis et al, 1982), i.e. with similar structures (homogenous 
mixes) and those consisting of a mixture of molecules (heterogeneous mixes) that are chemically 
and structurally unrelated. 
 
2.2.1 Homogenous Mixes 
This category consists of a mixture of molecules that are very similar in structure and reactivity. 
The factors controlling molecular recognition during the elicitation phase of the allergic response 
are highly dependent on the chemical group and the spatial geometry of the molecule. All the 
molecules have the same chemical reactivity, are metabolized in the same way and have analogous 
physicochemical properties. 
 
2.2.2 Heterogeneous Mixes 
This category is the most challenging for the chemist, since the presence, in the mixtures, of several 
molecules which differ widely in size and reactivity, can result in many interactions during skin 
penetration, bio-distribution of molecules between the various skin compartments, during 
metabolism, or with antigen-presenting cells. 
Perfumes fall into this complex category, as do the test materials to identify fragrance allergy (see 
below), with all problems inherent in the use of molecular mixtures, either during the sensitization 
or challenge phases. Indeed, fragrance allergens are not inert entities, but are liable to undergo 
modifications and/ or interactions with their surroundings, forming new compounds and leading to 
increased (synergistic) or decreased (antagonistic) allergenic reactivity. 
With regard to the diagnosis of contact allergy to fragrances, mixtures or impurities make the 
interpretation of patch-test results very difficult and have been the cause of many substances being 
classified as sensitizing agents, when the allergen was, in fact, a degradation product or impurity. 
Testing with mixtures of compounds is thus an important source of error. These effects are, as yet, 
poorly quantified, but deserve all our attention, since the prevention policy currently in use in 
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perfume industry, which takes the allergenic potential of isolated molecules into consideration, is 
clearly limited, and the increasing number of cases of sensitization to perfumes should prompt us to 
look at the perfume as a whole (Lepoittevin et al, 1998-Bonefeld et al, 2011), Figure 2. 
 
Figure 2 Model for the cocktail effect of fragrance allergens. Exposure to a single allergen induces only weak danger 
signals, and thereby weak activation of antigen-presenting cells (APCs), T cell activation, and memory T cell 
generation. However, exposure to a cocktail of allergens leads to enhanced danger signals, and thereby to a higher 
degree of APC and T cell activation and memory T cell generation. LN, lymph. (Bonefeld et al, 2011) (reprinted with 
permission by Wiley). 
 
2.3 Identification of fragrance allergens. Diagnostic markers 
Patch testing is a well-established method of diagnosing contact allergy. It aims to reproduce 
an eczematous reaction by applying allergens under occlusion on the intact skin of patients 
suspected to be sensitized. 
The allergen to be tested is diluted in a vehicle, most often white petrolatum, and applied on 
the skin in a test chamber for 2 days. The preferred test site is the upper back. The general principle 
is to use the highest concentration of a test material that does not provoke any irritation in order to 
avoid false-positive reactions; however, also false-negative reactions due to a too low concentration 
of the test material may occur (Lachapelle et al, 2012-Mowitz et al, 2012). Patients with a suspected 
contact allergy are tested with a baseline series of common allergens, sometimes together with 
additional allergens specific for each individual case. Patch-test reading is carried out twice, in most 
dermatology clinics on day 2-3, and again on day 4-7. The reactions are scored according to their 
morphological characteristics as – (negative), ?+ (doubtful reaction), + (weak positive reaction), ++ 
(strong positive reaction), +++ (extreme positive reaction), or IR (irritant reaction), as 
recommended by the ICDRG (Wahlberg et al, 2001). 
The main tool for diagnosing contact allergy to fragrances included in the European baseline 
patch-test series consists of fragrance mix I (FM I), Myroxylon pereirae (MP) or balsam of Peru, 
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and colophonium. More recently a second fragrance mix, i.e. FM II, was officially introduced as an 
additional marker in the baseline series in 2008 (Bruze et al, 2008). 
 
2.3.1 Fragrance Mix I 
FM I, or perfume mix I, was introduced for screening by Larsen (Larsen, 1977) in 1977 and 
concerns a heterogeneous mixture of seven individual components of varied nature and reactivity. It 
contains a naturally occurring plant material, i.e. Evernia prunastri (oak moss absolute) and six 
synthetic fragrances, i.e. isoeugenol, cinnamal, cinnamyl alcohol, hydroxycitronellal, eugenol, 
geraniol and -amyl cinnamal (FM I 8% in petrolatum and each component of the mixture at 1% 
with sorbitan sesquioleate as an emulsifier). It has been included in the baseline series for many 
years. Compared to certain preparations, which contain more than 300 different molecules, it is a 
very simple “perfume” (Lepoittevin et al, 1998), but it can be used to illustrate the different aspects 
of, and problems inherent to molecular mixtures. 
Indeed, the fragrance mix (Fig. 3), as well as other natural products such as Myroxylon 
pereirae, colophonium, and essential oils must be considered as a whole, rather than simply as the 
sum of its components, a point clearly made by the experience of many clinicians. Certainly, a 
positive response to the mix is not always accompanied by a positive result to one, or more of the 
constituents tested in isolation, which indicates that the mixture has a marked synergistic effect. 
And it is highly probable that this observation, made during testing (challenge), applies equally well 
to the sensitization stage. 
As simple chemicals, FM I contains three large terpene ‘families’: 
1. Three cinnamic derivatives 
2. Eugenol and isoeugenol 
3. Two linear monoterpenes (hydroxycitronellal and geraniol). 
These three families of molecules differ greatly, not only in their structure, but also in their way of 
sensitization. 
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Figure 3. Fragrance-mix positive patch test. 
 
Cinnamic derivatives 
The three derivatives in the mix have different sensitization profiles: cinnamal and α-
amylcinnamal can be considered as haptens, whereas cinnamyl alcohol, beside being a hapten 
(Bickers et al, 2005), was considered a pro-hapten, that can be partially metabolised to cinnamal. 
However, in addition, a recent study showed that cinnamyl alcohol autoxidizes rapidly upon air 
exposure, forming a highly allergenic expoxide and cinnamal, hence it also acts a prehapten 
(Niklasson et al, 2013). The joint presence of cinnamyl alcohol and cinnamal can result in an 
enzyme reaction in equilibrium (Figure 4), which is displaced as a function of the respective 
amounts of the two molecules. 
 
 
 
Figure 4. Cinnamal and cinnamyl alcohol  
 
Eugenol and isoeugenol 
Both molecules must undergo a metabolic oxidation step (in this case, a more complex one 
than with cinnamyl alcohol) to form the reactive hapten. Recent studies on the mechanism of 
activation of both molecules seem to indicate that they follow different metabolic pathways, 
explaining the observed difference in reactivity and the low degree of allergic cross-reaction 
between them (Bertrand et al, 1997-Johansen et al, 1997). Eugenol, the weaker sensitizing agent, 
seems to require an initial demethylation step, forming a catechol, which is then oxidized to the 
highly reactive ortho-quinone (Figure 5); on the other hand, isoeugenol is itself sufficiently reactive 
to be directly oxidized to the equally highly reactive paraquinone methide (Figure 6). 
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Figure 5. Eugenol 
 
Figure 6. Isoeugenol 
Moreover, also other derivatives such as trans-isoeugenol and isoeugenol-esters do react in 
patients sensitized to the parent compounds (Figure 7). Indeed, ester derivatives, such as eugenyl- 
and isoeugenyl acetate that are also used as fragrance ingredients (Tanaka et al, 2004), do cross-
react with the alcohols, since they are hydrolyzed by esterases in the skin. 
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Figure 7.Positive patch test reactions to isoeugenol derivatives in isoeugenol-sensitive patients 
 
Linear Monoterpene derivatives 
This concerns geraniol, which is oxidized to the aldehyde, and hydroxycitronnellal, an 
aldehyde hapten. Again, the problem of the joint presence of an alcohol and aldehyde of related 
structure arises, together with the possibility of altered enzymatic metabolism (Hagvall et al, 2008-
2012). 
As previously said, geraniol acts both as a pro-hapten and pre-hapten. Testing with 
higher concentrations of oxidized geraniol and pure geraniol detects more patients than pure 
geraniol alone; but patch testing with only oxidized geraniol does not detect all cases of 
contact allergy to geraniol either. This indicates that other compounds formed may be 
important haptens as well. (Hagvall et al, 2013).  
 
Evernia prunastri (Oak moss) 
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Oak moss absolute has been among the most frequent sensitizing ingredients in FM I, with 
positive reactions in 2.2-3.4% of patch-tested eczema patients (Hendricks et al, 1999-Frosch et al, 
1995). Botanically, oak moss is the lichen, Evernia prunastri, which grows primarily on oak trees 
(Johansen et al, 2002). It is collected all over central and southern Europe, particularly in the former 
Yugoslavia and in France, but also in Morocco and Algeria. It has been considered the finest raw 
material for the production of perfume extracts. 
Oak moss contains a large number of ingredients, including atranalol and chloroatranalol, 
which are among the most allergenic substances ever identified (Johansen et al, 2002), and this at 
extremely low concentrations, i.e. 0.1 p.p.m. In addition, it was shown that polymer-based treatment 
of oak moss extract reduces the allergenic elicitation potential in previously sensitized individuals 
only to a minor extent. Therefore, it must be considered that the residual concentrations of atranol 
and chloroatranol being less than 75 p.p.m. and 25 p.p.m., respectively, are still far too high to be 
safe regarding elicitation (Nardelli et al, 2009).  
In the past, it has also been shown that the oak moss absolute used by the perfume industry 
as well as some patch-test materials contained resin acids, which were typically of another lichen 
extract, i.e. tree moss (Lepoittevin et al, 2000). Indeed, the fragrance industry often used mixtures 
of oak moss and tree moss, in order to improve the odor quality and to reduce costs, since the 
extracts from tree moss, Evernia furfuracea, are much cheaper than those from oak moss (Johansen 
et al, 2002). Tree moss is produced from a mixture of lichens growing on pine trees and small 
branches or pieces of bark may be present in the raw material, being most probably the source of 
the resin acids. The admixture of tree moss to oak moss may occur already at the time of harvesting 
and in this way the contamination of oak moss with tree moss resins acids may occur both 
unintentionally and deliberately. This means that, with regard to the diagnosis, contamination of oak 
moss patch test material with tree moss extract and thus (oxidized) resin acids, i.e. dehydroabietic 
and abietic acids, can lead to misdiagnosis, as these substances, or rather their oxidization products, 
are known allergens present in colophonium (Lepoittevin et al, 2000), with which it often co-reacts. 
 
2.3.2 Myroxylon pereirae (balsam of Peru) 
The natural product Myroxylon pereirae (MP) (balsam of Peru) is also used as a diagnostic 
marker for fragrance allergy in the European baseline series. It originates from a tree which grows 
in Central America and has been used as a fragrance ingredient due to its odorous properties. In 
fact, the crude Peru Balsam is not used in perfumery and has not been used since 1982 when de 
International Fragrance Association (IFRA) first banned its use in fragrances. However, since 1995 
(Api, 2006-Avalos-Peralta et al, 2005) Peru Balsam has been incorporated in fragrances as an 
extract or distillate, however, seems to be as allergenic as the crude product. In fact, patients allergic 
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to this allergen as present in the baseline series do react with the same degree of severity to the 
extract and distillate (Figure 8). 
 
Figure 8. Strong positive patch tests to Myroxylon pereirae as tested in the baseline 
series (panel A) but also to the “absolute” and “oil” as used in perfumery (panel B). 
 
Hjorth had already reported in 1961 that gums and resins such as balsam of Peru and 
benzoin are strong sensitizers, and associated with fragrance allergy (Hjorth, 1961) and that the 
most important allergens are formed by the polymerization of a ‘protoresin” (monomer or low 
polymer), which is an ester of benzoic acid or cinnamic acid and coniferyl alcohol; however, many 
other allergenic components are present as well, such as benzyl cinnamate, eugenol, methyl 
cinnamate, benzyl benzoate, vanillin, cinnamic acid, cinnamic alcohol, cinnamal, benzyl salicylate 
(Larsen, 1977), all components of, or related to other allergenic fragrance materials. 
 
2.3.3 Colophonium 
 Colophonium is another natural product tested in the baseline series and is obtained from 
pine trees, which contains allergenic oxidized resin acids (terpenes), mainly abietic and 
dehydroabietic acids. Simultaneous reactions are often observed with other fragrance allergens 
(Karlberg et al, 1988-1991), such as FM I, MP, and even compositae (asteraceae) plants, which is 
due to the (oxidized) terpenes present (Paulsen et al, 2005).  
Of course, colophonium has mainly other applications, such as in depilating wax, glues- also for 
shoes, adhesives tapes, rubber, wax for musical instruments, etc. (Vandebuerie et al, 2014) 
 
2.3.4 Fragrance Mix II 
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A newer screening substance has emerged from multicenter studies in order to increase the 
ability to diagnose fragrance allergy (Frosch et al, 2005a-b). As a result of this, since 2005, a 
mixture of 6 additional fragrance materials has been commercialized for introduction into the 
baseline series, i.e. fragrance mix II (FM II) that contains hydroxyisohexyl 3-cyclohexene 
carboxaldehyde (HICC)(Lyral®)(2,5 %), citral (1%), farnesol (2,5%), coumarin (2,5%), citronellol 
(0,5%), and α-hexyl-cinnamic aldehyde (5%) (FM II 14% in petrolatum). Moreover, 
hydroxyisohexyl 3-cyclohexene carboxaldehyde 5% was added to the baseline series separately as 
well. 
 
HICC (hydroxyisohexyl 3-cyclohexene carboxaldehyde) 
 
 
Figure 9. Hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC)  
 
HICC (Figure 9) has been used for many years without restrictions. It is related to 
hydroxycitronellal and has probably been used as a substitute since the use of the latter had been 
restricted, with generally high use concentrations, being more than 3.0% in certain perfumes (Fenn, 
1989). A series of systematic investigations under the leadership of Frosch have shown that HICC 
turned out to be one of the most frequent allergens, giving positive reactions in 1–2.7% of 
consecutively patch-tested patients (Frosch et al, 1995-1999-2002-2005). 
2.4% of patients tested by the Danish monitoring network of dermatologists were found to be 
allergic to HICC in 2005-2008 (with no decreasing trend from 2003 to 2007); in 70% of the cases 
the reaction was of current relevance, i.e. causing disease (Heisterberg et al, 2010). This is in 
agreement with the results of a later German study, in which 48 out of 51 patients (94.1%) with a 
positive patch test reaction to HICC also reacted in a repeated open application test, simulating 
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normal use conditions of cosmetics containing it (Schnuch et al, 2009). In a Danish study 69% of 14 
HICC allergic individuals developed allergic contact dermatitis from use of cosmetics containing 
this component in realistic amounts (Jorgensen et al, 2007). 
 
Farnesol 
 
 
 
Figure 10. Farnesol 
 
Farnesol (Figure 10) is both used as a fragrance ingredient and, at a higher concentration, also as a 
biocide, e.g., in deodorants (Frosch et al, 2002). It is has been shown to cause contact allergy in 
1.1% of patients consecutively patch tested by the German Information Network of Departments of 
Dermatology (IDVK) (Schnuch et al, 2004). Those subjects positive to farnesol were characterized 
by being young females and having hands and face more often affected than patients negative to it 
(Schnuch et al, 2004). Probably, many cases of deodorant contact allergy may have been missed in 
the past, since most of the farnesol-positive patients are negative to FM I (Frosch et al 2002-2005-
Goossens et al, 1997). 
 
Citral 
 
 
 
Figure 11. Citral 
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Citral (Figure 11) is a relatively weak allergen and has also irritant properties, which seem to be 
temperature dependent (Rothenborg et al, 1977). It has a steep dose–response curve (Heydorn et al, 
2003a) and has been shown to be of possible significance in patients with long-term chronic hand 
eczema, which may be due to its combined allergenic and irritant effects (Heydorn et al 2003a-b). 
In European multicentre studies, 0.7–1.1% of consecutively tested eczema patients gave a positive 
reaction to it (Frosch et al, 2002-2005a). 
 
Coumarin 
 
 
 
Figure 12. Coumarin 
 
Coumarin (Figure 12) has been the subject of several studies and case investigations (Frosch et al, 
2002-Mutterer et al, 1999). It has been reported to cause reactions in 0.4% of consecutively tested 
patients (Kunkeler et al, 1998) and also to give rise to positive reactions in 0.3% of patients in a 
European multicentre study (Frosch et al, 2002). However, in the most recent European 
investigation, it gave no reactions among 1,701 patients tested (Frosch et al, 2005a). The reason for 
this is unknown, but may be related to the actual use of a better quality of coumarin containing 
fewer sensitizing impurities. 
 
2.3.5 Other potential fragrance-allergy markers 
 
Limonene contained in the citrus fruits has an increasing significance, both as a solvent and 
fragrance ingredient, not only in fine fragrances, but also in many consumer (cosmetics, household) 
and industrial products, and this at rather high concentrations. The terpenes, i.e. d- and l-limonene 
(Skold et al, 2002-2004) easily oxidize on air exposure, and European studies have shown that 
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limonene (as is the case with other terpenes such as linalool and caryophyllene), are not allergenic 
themselves but that their oxidation products are, the strongest allergens formed being mainly 
hydroperoxides (Skold et al, 2002-2004). Antioxidants such as butylated hydroxytoluene (BHT) 
are, therefore, often added to commercial products. Testing consecutive patients in different clinics 
with oxidized d-limonene gave positive results in 0.3–6.5% of the cases (Matura et al, 2002). Of the 
patients reacting to the oxidized terpenes, 58% had fragrance related contact allergy and/or a 
positive history for adverse reactions to fragrance (Matura et al, 2005). Moreover, also oxidized 
linalool has been shown to be a frequent allergen on routine patch testing (Bråred Christensson et 
al, 2012). 
This emphasizes the need for testing with the chemicals that are in the products and not just what 
was originally added, and one or more of these oxidation products certainly deserve a place in the 
baseline series, particularly since the patch test materials of the oxidized forms of linalool (Skold et 
al, 2002-2004) and limonene are now commercially available (Bråred Christensson et al, 2012, 
Bråred Christensson et al, 2013). In terms of prevention, expiry dates taking auto-oxidation into 
consideration will help to solve the problem. 
Beside limonene and linalool, also linalyl acetate, alpha-terpinene and geraniol have all been 
identified as prehaptens. It is possible to prevent activation outside the body to a certain extent by 
different measures, e.g. prevention of air exposure during handling and storage of the ingredients 
and the final product, and by the addition of suitable antioxidants. When antioxidants are used, care 
should be taken that they will not be activated themselves and thereby form new sensitizers. 
Moreover, oxidized antioxidants lose their activity (Bråred Christensson et al, 2012). 
 
Essential oils as fragrance allergens 
 
About thousand years ago, the Arabs discovered how to extract oils from flowers by distillation 
and, thereby, produced essential oils. These skills spread to the Western Europe with the crusades. 
Essential oils come from many different plants, from a limited number of animals, and can be 
synthesized from two fossil oils (coal and petroleum) (EU Directive, 2003). Oils of roses, laurel and 
lavender are examples of essential oils obtained by steam distillation of plant raw materials, such as 
blossoms, leaves and fruits of flowers. Cedar-wood oil and sandalwood oil come from the wood and 
roots of trees (de Groot et al 1997). 
Until the mid-19th century, all perfumes were blends of essential oils. Nowadays, they are still 
present in many perfumes, are increasingly used as bath additives, added to shampoos, in skin oils 
and lotions, in flower waters, or in massage oils (Scheinman, 1996), and in aromatherapy either by 
application to the skin, or by inhalation through vaporization. For examples, essential oils such as 
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ylang-ylang (YY) or sandalwood oil have gained special attention in aromatherapy and are often 
applied directly to the skin in high concentrations for the treatment of headache, muscular pains, 
arthritis, etc. 
Essential oils are mostly constituted of terpenes such as α and β pinene, citral, geraniol, linalool, 
citronellal, hydroxycitronellal, limonene and menthol, but also contain other organic chemical 
compounds, including aromatics, aliphatics, alicyclics and heterocyclics. Examples of isolated 
substances include eugenol from cloverleaf oil, cedrol from cedarwood oil, citral from lemon grass 
oil, and menthol from peppermint oil. Linalool is a component of lavender, ylang-ylang, cananga, 
rosewood, Bulgarian rose and jasmine oils (Cockayne et al, 1997). Cinnamic alcohol is found in 
hyacinth oil, cinnamal in patchouli oil, eugenol in patchouli and clove oils, and isoeugenol in ylang-
ylang oil. Geraniol is present in most essential oils and is the main component of rose and 
palmarose oil, geranium, citronella, lavender and jasmine oil (de Groot et al, 1997). The results of 
an European study have shown that there are at least four essential oils that have produced positive 
test reactions in consecutively tested patients at a frequency of over 1%, i.e. Ylang Ylang oils (I and 
II), lemongrass oil, narcissus absolute and jasmine absolute, which are potential additional 
screening agents (Frosch et al, 2002). 
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Chapter 3 
 
Legislation on Fragrances 
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III. SAFETY MEASURES AND LEGISLATION 
In order to reduce the skin hazards of fragrance materials, a good historical example of successful 
cooperation between dermatologists and manufacturers concerns the story of “pigmented cosmetic 
dermatitis in Japan”, where in the 1960s, an epidemic occurred among women who presented with 
bizarre hyper-pigmentation of the face. Cosmetic ingredients were finally discovered as the culprit, 
i.e. coal-tar-derived dyes and various fragrances. On the basis of extensive patch tests studies, 
Nakayama and colleagues (Nakayama et al, 1984) developed the “allergen control system” for the 
production of safer cosmetics. Since major cosmetic companies in Japan avoided or reduced the 
concentration of these chemicals, the number of patients suffering from this disfiguring condition 
sharply declined. 
The impact of sensitization to a specific allergen in the general population is mostly derived from 
studies in clinical patch-test populations. These findings may result into preventive and regulatory 
decisions, in the case of fragrance allergy -undoubtedly a matter of concern- it remains 
controversial as to how and against which of the different compounds preventive action should be 
taken (Schnuch et al, 2004). Because of the increasing importance of fragrance allergy and to 
ensure that sensitized consumers are adequately informed, since March 2005, 26 fragrance 
components have been labeled as cosmetic ingredients on the packaging (see below). Based on the 
expansion of our knowledge of fragrance allergy, also by results obtained within the frame of the 
European research project on Fragrance Allergy from April 2000 to March 2003 (EU Directive 
2003), test series of fragrance substances have been updated, which enables not only to better 
identify fragrance-sensitive patients but also to outline the pattern of sensitivity to major and minor 
components. Moreover, as a result of this research project the concentration of certain fragrance 
chemicals, e.g. isoeugenol and hydroxy-isohexyl cyclohexene carboxaldehyde, shown to be strong 
allergens even in low concentrations, has been reduced. 
 
3.1.1 The 26 fragrance allergens labeled on the packing 
Ingredient labeling of 26 individual fragrance ingredients, identified as allergens in humans, 
was thus introduced for cosmetics in the EU in 2005: amyl cinnamal, cinnamyl alcohol, cinnamal, 
Evernia prunastri (oak moss), Evernia furfuracea (tree moss), eugenol, geraniol, 
hydroxycitronellal, iso-eugenol, alpha-isomethyl ionone, amylcinnamyl alcohol, anisyl alcohol, 
benzyl alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate, citral, citronellol, coumarin, 
d-limonene, farnesol, hexyl cinnamal, hydroxyl-isohexyl cyclohexene carboxaldehyde (HICC), 
butylphenyl methylpropional (lilial), linalool, methyl heptine carbonate (Annex 3 of the Cosmetic 
Directive). The intention was to provide a tool for clinicians for optimizing the investigation of 
patients with suspected fragrance allergy, as well as for fragrance allergic patients for avoiding 
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products containing substances to which they are allergic. Both these aims are objectives of 
secondary prevention and seem to have been well accepted. In a study of fragrance allergic patients 
and their utilization of ingredient labeling (Lysdal et al, 2009), most responded that they indeed 
used it (86.3%) and the majority (65.3%) of them found it helpful. Most allergic patients (83.2%) 
read the labels to find out if the product was scented, while 35.6% also looked for specific 
ingredients. Many (84.9%) considered that a clearer labeling, e.g. easier names and a larger font 
size, would increase their benefit. 
The restrictions set are identical for all 26 substances and are detailed under “other limitations and 
requirements”: i.e., “the presence of the substance must be indicated in the list of ingredients 
referred to in Article 6 (1) (g) when its concentration exceeds 0.001% in leave-on products and 
0,01% in rinse-off products” (independent of their function in the products). This list of compounds 
was set up by the expert groups for “fragrances with possible allergenic potential” of the SCCNFP 
(Scientific Committee on Cosmetics and Non- Food Products) –later known as SCCP-, a selected 
group of mainly toxicologists working at universities and authorities advising the European 
Commission. The regulations on fragrances in cosmetic products were taken over for washing and 
cleansing products by Regulation EG/648/2004 (EC, 2004, 2006a), for which the presence of any of 
these 26 allergens must be indicated in the list of ingredients when its concentration exceeds 0.01%. 
In the case of hydroxyisohexyl 3-cyclohexene carboxaldehyde, in 2003 the SCCP previously 
suggested that levels of up to 200 ppm would be tolerated by the majority of sensitized individuals. 
Recent voluntary restrictions (recommendations to such lower use concentrations, at least for some 
product types) are not reflected in available evidence. The SCCS thus considered that the number of 
cases of HICC allergy documented over the last decade is exceptionally high and that continued 
exposure to HICC by the consumer is not considered safe, even at concentrations as low as 200 
ppm. Therefore, they advised that HICC should not be used in consumer products, in order to 
prevent further cases of contact allergy to HICC and to limit the consequences to those who already 
have become sensitized (SCCS Opinion, 2012). 
 
3.1.2 Further restrictions and other fragrance allergens to be taken into consideration  
 
The expert groups for fragrances with possible allergenic potential (SCCP) have been 
constantly evaluating the scientific literature with a systematic and critical review, in order to 
identify additional fragrance substances expected to be contact allergens, including natural extracts, 
and also fragrance substances that can act as pre- or pro-haptens, forming new or more potent 
allergens by air oxidation and/or metabolic activation relevant for consumers (SCCS Opinion, 
2011). 
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 Based on clinical experience, the most recent SCCP Opinion thus considered 82 substances, 
54 single chemicals and 28 natural extracts (essential oils), which can be classified as established 
contact allergens in humans (SCCS Opinion, 2012). At this moment, following a referral to the 
European Commission, the SCCS has made a number of recommendations to amend Annexes II 
(banned substances) and III (to appear on product labeling). The ban covers HICC, atranol and 
chloroatranol and 12 + 8 natural extracts should be subject to mandatory labeling (ec.europa.eu, 
2014). 
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Chapter 4 
 
 Objectives and Methods 
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General Objectives 
1- To describe the frequency of contact allergy to fragrance allergy “markers” as tested in the 
baseline (standard) series, i.e. FM I, FM II, Myroxylon pereirae (MP) and colophonium, and 
to determine trends in frequency over the years. To characterize the age, sex, and lesion 
location of the fragrance-allergic patients and to study the association between the positive 
tests observed with these markers. 
2- To also describe the frequency of positive reactions to the FM I- and FM II- individual 
components, and determine the trends in their frequency over the years. Furthermore, to 
determine association between positively reacting FM I ingredients and Myroxylon pereirae 
(MP), and colophonium. 
3- To investigate whether the chemically modified oak moss absolute, treated by a polymer-
based method and containing reduced amounts of chloroatranol and atranol, still produced 
positive patch-test reactions in previously sensitized subjects. 
4- To identify fragrance allergens other than those tested in the baseline (standard) series. 
5- To determine which and how many topical pharmaceutical products marketed in Belgium 
contain fragrances and to examine the nature of the fragrances in specific products that 
played a role in iatrogenic allergic contact dermatitis (ACD) in the patient population 
investigated. 
6- To identify the nature of fragrance allergens responsible for ACD from specific cosmetic 
products. 
 
Methods 
4. Patient population 
 
We studied consecutive patients presenting with eczematous dermatitis at the Contact Allergy 
Unit (Department of Dermatology) of the Katholieke Universiteit Leuven, between 1990 and 2011, 
and who were patch tested with a European baseline patch test series (Hermal, Reinbeck, 
Germany), and, when indicated, also with other contact allergens. This concerned 13,332 subjects, 
of whom  7486 (56%) presented with at least one positive reaction. The MOAHLFA (Schnuch et al, 
1997; Uter et al, 2008) index for this patient group was: M (Male), 34%; O (Occupational 
dermatitis), 17%; A (Atopic dermatitis), 22%; H (Hand dermatitis), 38%; L (Leg dermatitis), 3,5%; 
F (Facial dermatitis), 35%; and A (Above 40 years), 48%. 
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 The patch tests were administered with van der Bend patch-test chambers (Brielle, the 
Netherlands) applied on the back with Micropore™ (3M Health Care, Borken, Germany), and fixed 
with Fixomull® (Beiersdorf, Germany), and later on with Mefix® (Mölnlycke Health Care, 
Göteborg, Sweden) as adhesive tape. The patch-test readings were performed according to the 
international guidelines by the ICDRG after 2 days, 3 days (exceptionally), and 4 days, and 
sometimes also later. 
 
5. Data sources 
 
The data compiled in the electronic databases developed in our center since 1978 were 
analyzed. Beside a patient file with clinical and patch test data, these databases also contain a 
product and a literature file. The product file concerns information on the complete composition of 
topical pharmaceutical products (n=3280) and cosmetics (n=1742) (delivered by pharmacists) in 
Belgium, allowing to identify the allergens present in these products. The literature file is 
specifically focused on contact dermatitis and includes references since 1967 (n=13.067). 
 
6. Substances tested 
 The European baseline (standard) patch test series includes a 'fragrance mix', also called 
‘fragrance mix I’ or FM I 8% in petrolatum, for better distinction with the newly developed 
'fragrance mix II or FM II (see below). FM I is a mixture of 7 synthetic fragrances, i.e. alpha-amyl 
cinnamal, cinnamal, cinnamyl alcohol, eugenol, geraniol, hydroxycitronellal, isoeugenol, and the 
natural compound Evernia prunastri (oak moss absolute), all at a concentration of 1% each. The 
baseline series also includes Myroxylon pereirae [balsam of Peru (MP)] and colophonium. MP is a 
natural extract prepared from the exudation of the tree MP and was reported in 1961, together with 
other gums and resins such as benzoin, to be an important marker for fragrance allergy. The other 
allergenic ingredients include benzyl cinnamate, methyl cinnamate, benzyl benzoate, vanillin, 
cinnamic acid, benzyl salicylate, cinnamyl alcohol, cinnamal and eugenol. The latter 3 chemicals 
are also present in FM I. 
 It has been reported that as much as 33% of fragrance sensitivity may be missed if FM I is 
used as the only test substance to detect fragrance allergy. To compensate the unsatisfactory 
sensitivity of the FM I (and MP and colophonium) in the diagnosis of contact allergy to currently 
used fragrances, an additional marker, i.e. FM II was developed (14% in petrolatum) and introduced 
officially into the baseline series in 2008 (Bruze et al, 2008). FM II contains citral, citronellol, 
coumarin, farnesol, hexyl cinnamal, and hydroxyisohexyl cyclohexene carboxaldehyde (HICC), the 
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latter which is also tested separately (5% in petrolatum). Sometimes other fragrance-allergens such 
as the (oxidized) terpenes linalool and limonene, essential oils, and specific fragrance-containing 
products used by the patients have been tested as well. 
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Abstract 
 
Background: The widespread use of fragrance-containing products is probably the most important 
reason for its high impact in allergic contact dermatitis. 
Objectives: To describe the frequency of contact allergy to fragrance allergens as tested in the 
standard series, in relation to age, sex and lesion locations. To determine trends in frequency over 
the years and to study the association between positive tests observed with the different fragrance-
allergy markers as well as between specific fragrance allergens and locations of the lesions. 
Patients/Methods: 10 128 patients underwent patch testing between January 1990 and December 
2005 at the Dermatology department in Leuven. 
Results: 1463(14.5%), that is, 380(26%)males and 1083 (74%) females, reacted positively to at least 
1 fragrance-allergy marker in the standard series: 9% to fragrance mix I, 6% to Myroxylon pereirae, 
and 4.8% to colophonium (often in association), 2.1% to hydroxyisohexyl 3-cyclohexene 
carboxaldehyde and 2.1% to fragrance mix II, the latter 2 allergens having been introduced more 
recently. Over the years, fragrance contact allergy has shown a fluctuating trend. Hands and face 
were the most commonly affected body sites. Moreover, a significant association was found 
between specific fragrance allergens and certain locations. 
Conclusions: This study illustrates that fragrance contact allergy is common in patients suffering 
from contact dermatitis. 
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Introduction 
 Adverse reactions to fragrances in perfumes and cosmetic products include allergic contact 
dermatitis (ACD), irritant contact dermatitis, photosensitivity, immediate reactions (contact 
urticaria), pigmented contact dermatitis, and (worsening of) respiratory problems (de Groot, 2001). 
 Allergic contact dermatitis from fragrances results from a combination of repeated environ- 
mental exposure and age-related susceptibility factors (Buckley et al, 2003) and is commonly 
observed in patch-test populations. Allergenic fragrance chemicals are indeed ubiquitous in our 
environment, not only in fine fragrances but also in a wide range of cosmetic, household, and 
industrial products (Matura et al, 2003) and even topical medicaments. Actually, together with 
preservative agents, they are the most important sensitizing culprits in cosmetic products (Goossens, 
2006- Schnuch et al, 2004), with a frequency that is estimated to be around 1.5% in the general 
population (Denmark, 1.1% and Norway, 1.8%) (Nielsen et al, 1992- Dotterud et al, 2007) and 
between 6–14% in contact dermatitis patients (Marks et al, 1998). 
 The main tool for diagnosing contact allergy to fragrances is the European standard patch-test 
series. This standard series consists of (i) fragrance mix I (FM I), a mixture of 1 natural compound, 
oak moss absolute (Evernia prunastri), and the synthetic fragrances isoeugenol, hydroxycitronellal, 
cinnamal, cinnamic alcohol, eugenol, -amyl cinnamal, and geraniol, at a concentration of 1% each, 
(ii) Myroxylon pereirae (MP or balsam of Peru), and to a less extend also (iii) colophonium. New 
screening substances have emerged from multi- center studies in order to increase the ability to 
diagnose fragrance allergy (Frosch et al, 2005 a-b). As a result of this, since 2005, a mixture of 6 
additional fragrance materials has been commercialized for future introduction into the standard 
series, that is, fragrance mix II (FM II) that contains hydroxyisohexyl 3-cyclohexene carboxaldehyde 
(HICC or Lyral), citral, farnesol, coumarin, citronellol, and -hexyl cinnamal. 
 The aims of this retrospective study were as follows: 
(1) To describe the frequency of contact allergy to fragrance allergens as tested in the standard 
series. 
(2) To determine trends in frequency over the years. 
(3) To characterize the age, sex, and lesion location of the fragrance-allergic patients. 
(4) To study the association between the positive tests observed with the different fragrance-allergy 
markers. 
(5) To study the association between specific fragrance allergens and localization of the dermatitis. 
 
Materials and Methods 
 
 From January 1990 until December 2005, 10 128 consecutive patients presenting with 
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eczematous dermatitis were patch tested in the Contact Allergy Unit of the Katholieke Universiteit 
Leuven with a European Standard series (Hermal, Reinbeck, Germany) and (when indicated) also 
with other allergens. 
 The patch tests were administered with Van Der Bend patch-test chambers (Van Der Bend, 
Brielle, the Netherlands) applied on the back with MicroporeÔ (3M Health Care, Borken, Germany) 
and fixed with Fixomull1 (Beiersdorf, Germany) and later on with Mefix1 (Mölnlycke Health Care, 
Goteborg, Sweden) as adhesive tapes. The patch-tested readings were performed according to the 
international guidelines by the International Contact Dermatitis Research Group (Wahlberg, 2001) 
after 2 days, 3 days (exceptionally) and 4 days and sometimes later. 
 All data were retrieved from and evaluated with a patient database developed in our 
department (Drieghe et al, 2002- Goossens, 1998). The fragrance-related allergens present in the 
standard series were studied in an explorative way. In the study of associations between patch- test 
results and the location of the lesions, the data were presented in a 2x2 contingency table. As an 
appropriate statistical measure to compute the strength and the direction of the association, we used 
the odds ratio (OR), expressing the occurrence of positive reactions in 1 group as compared with 
another group, and/or the relative risk, and their corresponding 95% confidence interval (CI). If the 
CI is different from the value 1, there is a significant association between the row and the column 
variables. The statistical analysis in both the male and the female populations was per- formed by 
using the SAS SOFTWARE SYSTEM version 9.1 (SAS Institute Inc., Cary, NC, USA). 
 
Results 
 Among the entire population of 10 128 patients patch tested, 3491 were males (34.5%) and 
6637 were females (65.5%). 5690 (56%) presented with a contact-allergic reaction to at least 1 of 
the substances tested, and 1463 (14.5%), that is, 380 (26%) males and 1083 (74%) females, reacted 
positively to at least 1 fragrance marker, making up 26% of those with contact allergy. 
 The OR for females is 0.19 (odds f= 1083/ 5554 = 0.1950), expressing the probability to have 
a positive reaction to be 0.19 higher than the probability of having a negative reaction to fragrance. 
The odds for males is only 0.12 (odds m= 380/3111= 0.1221). The OR is then 1.6 with a 95% CI 
(1.41–1.81) or the probability of having a positive patch-test reaction in females being 1.6 times 
larger than in males. 
 The mean age in fragrance-allergic patients was 45 for males and 44 for females (both with 
17 SD), compared with 39 years both for males and females (17 SD) in the non-fragrance allergic 
patients (n= 8665). For a more convenient handling of the data, the age of the patients was divided 
into groups with a span of 20 years (Fig. 1). The frequency of fragrance allergy gradually increased 
from young to adult age, the highest peak between 20 and 40 years (40%) for females and between 
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40 and 60 years (37.6%) for males, to decrease gradually again later on. 
Fig. 1. Distribution of age of fragrance- (right panel) and non-fragrance allergic patients (left 
panel). 
In the whole group, there were 3626 atopic patients (36%) (atopic dermatitis, asthma and/or 
allergic rhinitis), 521 of whom (14.4%) presented with a positive reaction to at least 1 fragrance- 
allergy marker, compared with 942 (14.5%) in the 6502 non-atopic patients (64%). Thus, positive 
reactions to a fragrance-allergy marker and atopy were not significantly associated. 
 As regarding the fragrance-allergy markers, 9% of the population tested (n= 924) presented 
with a positive reaction to FM I, 6% (n= 617) to MP, 4.8% (n= 489) to colophonium (Table 1), 
2.1% (n= 62 in 2901 patients tested) to HICC, and 2.1% (n= 7 in 335 patients tested) to FM II, the 
latter allergens being introduced more recently, in 2002 and 2005, respectively. 30 patients out of 
62 (48.4%) reacted both to FM I and to HICC. The total number of positive reactions observed is, 
of course, higher than the number of patients as many of them suffered from multiple sensitivities. 
Among those reacting to FM I, MP, or colophonium, females represented 72%, 74%, and 77% and 
the males 28%, 26%, and 23%, respectively. 
 
Table 1. Positive reactions observed to fragrance mix I, Myroxylon pereirae and colophonium  
Markers Total (n= 10.128) % Male (n= 1463) Female (n= 6637) 
FM I 924 9.12 258 666 
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MP 617 6.09 162 455 
C 489 4.83 113 376 
FM I, fragrance Mix I; MP, Myroxylon Pereirae; C, colophonium. 
 The results of the positive patch-test reactions obtained with FM I, MP, and colophonium over 
the years are given in Table 2, which is illustrated in Fig. 2. 
 
 
 
Table 2. Percentage of positive patch-test results obtained with fragrance mix I, Myroxylon 
pereirae and colophonium over the years 
 
 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 
FMI 7.2 7.3 6.6 5.6 13.1 9.6 10.1 8.1 11.9 13.9 12.5 9.7 8.4 8.3 9.3 7.7 
MP 6.5 6.8 5.2 4.8 4.8 6.5 6.7 5.6 6.1 6.8 7.7 6.9 6.6 6.3 7.9 5.0 
C 5.5 5.5 3.7 3.8 6.1 4.8 4.7 3.7 6.3 5.7 5.6 5.4 4.6 4.3 5.3 4.3 
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Fig. 2. Evolution of the relative frequency over the years of positive reactions to fragrance-allergy 
markers. C, Colophonium; FM, Fragrance Mix I; MP, Myroxylon Pereirae. 
 The associated positive tests observed with the different fragrance-allergy markers are given 
in Table 3 (multiple hypotheses testing for all the different fragrance-allergy markers were taken 
into account), showing a strong association for all comparisons reported. When the associations 
were significant, the OR was computed. As an example, an OR of 11 (Table 3) means that the odds 
of a positive reaction to colophonium is 11 times higher for patients with a positive reaction to FM I 
than for non-FM I allergic patients. 
Table 3. Odds ratios and corresponding 95 % CIs for the different fragrance-allergy markers 
 Males Females 
Allergens OR (95 % CI) OR (95 % CI) 
FM I and C 11.14 (7.48-16.59) 5.11 (4.05-6.46) 
FM I and MP 35.74 (24.98-51.15) 18.96 (15.35-23.42) 
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FM I and HICC 25.63 (6.37-103.10) 17.50 (10.09-30.34) 
C and MP 5.95 (3.65-9.70) 5.35 (4.14-6.92) 
 
C, Colophonium; CI, confidence interval; FM, fragrance mix I; HICC, hydroxy-isohexyl 
cyclohexene carboxaldehyde; MP, Myroxylon Pereirae; OR, odds ratio.  
 The localization of the lesions in the fragrance (n=1463) and non-fragrance (n= 8665) allergic 
patients are visualized in Fig. 3. Hands (31.2%), face (27.2%), lower legs (16.6%), and feet (15.3%) 
were the most commonly affected body sites infragrance-sensitive individuals, particularly in 
females. Significant associations were found for arms (relative risk, 1.24; 95% CI, 1.09–1.41), 
lower legs (relative risk, 1.71; 95% CI, 1.51–1.93) and upper legs (relative risk, 10.82; 95% CI, 
8.56– 13.68), and axillae (relative risk, 1.51; 95% CI, 1.21–1.90). For hands (relative risk, 0.8; 95% 
CI 0.76–0.93), there is a negative correlation with fragrance allergy though. 
 
 
Fig. 3. Visualisation of localisation of the lesions in fragrance-allergic (n= 1463) (right panel) and 
non-fragrance allergic patients (n= 8665) (left panel). 
Table 4 shows the results of the association between localization and specific fragrance allergens. 
Of 40 combinations of localization by marker, 9 were significantly associated either for males or for 
females, or both. As this was an explorative study, a correction for multiple comparisons was not 
used. 
Table 4. Odds ratios and corresponding 95 % CI for the association between localizations and the 
fragrance allergens 
 Males Females 
Allergens OR 95 % CI OR 95 % CI 
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Axillae and FM I 2.32 (1.29-4.16) 2.22 (1.54-3.20) 
Axillae and HICC 4.65ns (0.57-37.63)ns 7.28 (3.62-14.62) 
Trunk and HICC 1.20ns (0.15-9.64) ns 2.02 (1.01-4.02) 
Upper-leg and C 1.17ns (0,60-2.26)ns 1.48 (1.01-2.16 ) 
Upper-leg and MP 1.23 ns (0.71-2.13) ns 1.50 (1.06-2.12) 
Lower-leg and FM I 2.17 (1.58-2.99) 1.94 (1.55-2.43) 
Lower-leg and MP 2.07 (1.39-3.06) 2.20 (1.71-2.84) 
Lower-leg and C 1.96 (1.22-3.13) 2.10 (1.59-2.77) 
Feet and C 2.14 (1.40-3.25) 2.62 (2.03-3.39) 
 
C, Colophonium; CI, confidence interval; FM, fragrance mix I; HICC, hydroxy-isohexyl 
cyclohexene carboxaldehyde; MP, Myroxylon Pereirae; NS, non significant values; OR, odds ratio. 
Discussion 
 It is well known that after nickel, contact allergy to fragrance components is the most 
common finding among contact-allergy patients (de Groot et al, 1997-Nielsen et al, 1993). This was 
also true in our female population studied and, since 1995 to 2006, FM I and p-phenylenediamine 
(data not shown) were, in alter- nation, the 2 most frequent allergens in our male population. The 
majority of patients with fragrance sensitivity were women (Scheinman, 1996-Malanin et al, 1989-
Malten et al, 1984), which reflects a greater exposure to fragranced cosmetics in this population. 
However, in view of an increasing usage also in men, the sex difference may become less 
prominent in the future. 
Buckley et al. argued that ACD from fragrances has an age-related susceptibility (Buckley et al, 
2003) and observed a peak in the 60s for females and in the 70s for males (Buckley et al, 2003). 
The highest peak observed between the ages 20 and 40 in our female population could be explained 
by the greater personal use of fragranced products in young women in particular. In males, the 
highest peak was observed between the ages 40 and 60. This could perhaps be explained by a 
different patient selection or a different consumer exposure in both centres. 
 With regard to the fragrance-allergy markers, FM I has been regarded as an adequate 
screening test for fragrance sensitivity, although it has been reported that as much as 33% of 
fragrance sensitivity may be missed (Larsen et al, 1998), if it is used as the only test substance. This 
percentage is probably too low and depends on which fragrance chemicals or products the subjects 
are tested with. Indeed, the more fragrance allergens tested, the more positive reactions can be 
observed. In most epidemiological studies, as well in the current study, the patch-test result of 
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patients reacting to their own perfume and deodorant, for example, or to any other fragrance 
allergen, have not been considered. Besides FM I, our results also take into consideration MP and 
colophonium, for which, in agreement with other studies, including a recent report from Austria 
(Wohrl et al, 2001), positive reactions are significantly associated in both sexes. Indeed, this can be 
explained by the fact that these products share similar components. 
 In fact, Hjorth has already reported in 1961 that gums and resins such as MP and benzoin are 
strong sensitizers, associated with fragrance allergy (Hjorth, 1961). He showed that the most 
important allergen of MP is formed by the polymerization of a ‘protoresin’ (monomer or low 
polymer), which is an ester of benzoic acid or cinnamic acid and coniferyl alcohol; however, many 
other allergenic components are present such as benzyl cinnamate, eugenol, methyl cinnamate, 
benzyl benzoate, vanillin, cinnamic acid, cinnamic alcohol, cinnamal, and benzyl salicylate (Larsen, 
1977), all present in or related to other allergenic fragrance materials. The crude MP, as such, has 
not been used in perfumery since 1982, when the Inter- national Fragrance Association banned its 
use in fragrances. Since 1995 (Api, 2006a- Avalos-Peralta et al, 2005), MP has been incorporated in 
fragrances as an extract or distil- late, but could be, according to a recent study, as allergenic as the 
crude product (M. Bruze, Malmo “University Hospital, Lund University, Malmo”, Sweden, 
personal communication). 
 Colophonium, originating from pine trees (Karlberg et al, 1988), often co-reacts with 
fragrance allergens; their major constituents are resin acids, that is, abietic acid and dehydroabietic 
acid, of which the oxidized derivatives are responsible for contact allergy (Karlberg, 1991). The 
same allergens have also been identified in the FM I component ‘Evernia prunastri’ or ‘oak moss’, 
either as contaminants or as ingredients of ‘Evernia furfuracea’ or ‘tree moss’, also derived from 
pine trees and often used by the perfume industry as a cheaper substitute for oak moss (Johansen et 
al, 2002-Lepoittevin et al, 2000). Besides oxidized terpenes, however, oak moss contains a large 
number of other ingredients, including atranalol and chloroatranalol, which are perhaps among the 
most allergenic substances ever identified (Johansen et al, 2002), that is, still a 0.1 p.p.m. (the 
individual components of FM I will be discussed separately in a further study). 
 Besides FM I, MP, and colophonium, positive reactions to FM II, in which HICC is the most 
common sensitizer (Frosch et al, 2005 a-b), and HICC itself were also considered, although tested 
in a minority of the patients. The percentage of positive reactions found for HICC (2.1%) is in 
agreement with the prevalence found in other European studies, that is, 1.5–3% (Frosch et al, 2005 
a- Frosch et al, 1999-Frosch et al, 2002-Baxter et al, 2003-Nardelli et al, 2004). This is in contrast 
to North America where the prevalence was found to be only 0.4% (Belsito et al, 2006), the 
difference being attributed to the presence of HICC in high concentrations in deodorants in the EU, 
likely to induce sensitization in occluded areas. Contact allergy to a fragrance would have been 
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missed in 32 out of 62 (52%) patients if we had only tested with FM I and not with HICC. This is 
much higher than what has been reported by Frosch et al., that is, in 7.2% of the patients (Frosch et 
al, 1999-2002). Because of the low number of patient tested and reacting to FM II, we are not able 
to formulate any conclusion about missed reactions to this mixture. Frosch et al. previously reported 
that 1/3 of the patients reacting to FM II were negative to FM I (Frosch et al, 2005 b). Geier et al. in 
a large German study reported that 535 out of 6968 (7.7%) patients reacted to FM I, while 321 of 
6968 (4.6%) were positive to FM II. 151 of them reacted to both allergens, representing 28% of 
those with contact allergy to FM I and 47% of those allergic to FM II. FM II has thus acceptable 
diagnostic qualities and is helpful as an additional tool in detecting fragrance allergy (Geier et al, 
2006). 
 Concerning the trends in the fragrance sensitivity rate (Table 2 and Fig. 2), a fluctuating trend, 
either increasing or decreasing, was observed. For FM I, the frequency was highest from 1998 to 
2000 and has then decreased in recent years. In 2006 (data not shown), the frequency was the same 
as in 2001, that is, 9.65. In the past decade, the prevalence of fragrance sensitivity, evaluated by 
testing only with FM I, varied considerably. A percentage between 7 and 10 was observed among 
patch-tested patients in Europe (Schnuch et al, 2004- 1997-Temesvari et al, 2002-Bangha et al, 
1996-Hasan et al, 2005- Buckley et al, 2000). In Denmark, it rose from 4.1% in 1985–1986 to 9.9% 
in 1997–1998 (Johansen et al, 2000), and a similar rising tendency was reported in Slovenia as well 
(Lunder et al, 2000). However, a recent decrease in FM I sensitivity has been reported in several 
studies (Schnuch et al, 2004- Larsen et al, 1998- Wohrl et al, 2001- Schnuch et al, 1997- Temesvari 
et al, 2002), for example, according to a recent European multi-centre survey, the fragrance 
sensitivity rate has decreased significantly from 13.1% in 1999 to 7.8% in 2002 (Bruynzeel et al, 
2005). This was also observed in the USA, where the fragrance sensitivity rate diminished from 
14% to 11.4% in the late 1990s (Marks et al, 1998-Marks et al, 2000) and, according to a more 
recent study, even down to 5.9% (Belsito et al, 2006). In the future, perhaps a further decrease in 
positive reactions to FM I allergens may be expected. Indeed, because of the labelling of 26 
fragrance components by EU legislation (EU Directive, 2003), including those of FM I, as well as 
the outcome of recent dermatological studies on fragrance allergy and subsequent legal 
requirements [for example, reducing the concentration of isoeugenol (Tanaka et al, 2004)], the 
policy of some fragrance companies has changed. For instance, it has been shown that the new 
prestige perfumes contain less often or lesser amounts of fragrance chemicals included in FM I, 
compared with the older perfumes (Rastogi et al, 2003). Moreover, deodorants and domestic and 
occupational products quite often contain fragrance chemicals different from those present in FM I, 
such as limonene (Rastogi et al, 1998- Rastogi et al, 2001). This underlines the usefulness of new 
screening substances for the purpose of increasing the ability to diagnose fragrance allergy (Frosch 
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et al, 2005 a-b). In 2005, Hasan et al. have shown that in contrast to FM I, there is a significant 
increase in the sensitivity rate to MP in recent years (Hasan et al, 2005), whereas the sensitivity rate 
to MP has been rather stable over the years in our study. 
 As to the lesion localization, according to our study, hands, face, lower legs, and feet are the 
most commonly affected body sites. Although fragrance allergy is not significantly associated with 
hand dermatitis, the hands are the most frequently involved sites in fragrance-allergic women (in 
men, hand dermatitis is more often because of other, more occupation-related allergens). This is not 
surprising (Johansen et al, 1996-Heydorn et al, 2003 a-b) as many contactants do indeed contain 
fragrances: household products, cleaners, waxes, polishes, textile softeners, etc., and, of course, 
nearly all cosmetics (and many topical medications) are applied by the hands, sometimes also on the 
skin of other family members or pets (Scheinman, 2002). Moreover, patients may suffer first from 
irritant or atopic hand dermatitis, which may later be complicated by contact allergy to products 
used for treatment (fragranced topical drugs) or prevention (hand creams and lotions) or to other 
contacted perfumed products. Last but not least, dyshidrotic eruptions have been ascribed to 
ingestion of spices (Meynadier et al, 1986), which may contain fragrance chemicals or may cross-
react with them (Lehucher-Michel et al, 2000). 
 As to the face, the sensitive facial skin and the eyelids in particular are susceptible to develop 
ACD from fragranced skin-care products, decorative cosmetics, and cleansing preparations and 
sometimes even from airborne exposure (Dooms-Goossens, 1993a-Dooms-Goossens, 1993b). 
Moreover, microtraumata from shaving facilitate (photo) contact allergy to aftershave fragrances 
(Edman, 1994), but also other skin diseases such as atopic dermatitis and even facial psoriasis may 
be induced or aggravated by ACD from fragrances (de Groot et al, 1983). In our population, 
although the face was a common localization, the association with fragrance allergy was not 
significant. Indeed, preservative agents, in particular, and, to a lower extend, emulsifiers are also 
important cosmetic allergens causing ACD on the face. 
 Significant associations between the neck, skin behind the ear or de ́ collete ́ that are other 
usual sites of fragrance contact dermatitis were not observed. In these areas, nickel and cobalt 
present in cheap metal jewels are common allergens as well. The latter body sites as well as the 
axillae, notwithstanding its significant association with ‘fragrance’ allergy (Table 4), are certainly 
under- represented in our study. Indeed, in general, the relation with the causal product being 
obvious (Goossens et al, 1997- Svedman et al, 2003), patients consult because of dermatitis located 
elsewhere (which is indicated in our patient file as being the first site affected), and, after 
identification of fragrance allergy, they then often recall having previously suffered from skin 
reactions to toilet waters or deodorants, respectively. Reactions to FM I and to HICC (in females) 
were significantly associated with locations in the axillae, as has been reported earlier (Johansen et 
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al, 2003). 
 Contact allergy to FM I, colophonium, and also MP is often found in patients, especially 
females suffering from leg ulcers, who are exposed to fragrance-containing medications, adhesive 
tapes, etc. This will be investigated separately in a further study on iatrogenic dermatitis caused by 
fragrances. As to the feet, colophonium is certainly the main culprit in shoe dermatitis, not as a 
fragrance allergen, of course, but because it is used as a tackifier (Nardelli et al, 2004). 
 Significant, but perhaps unexpected associations between fragrance allergy and locations such 
as the trunk, arms, and also upper legs were found in females, although not with a specific fragrance 
chemical. This most probably reflects the use of fragrance-containing body creams and lotions and 
perhaps skin-cleansing products, in which, besides preservative agents, fragrances are the most 
important allergens. Furthermore, other existing eczematous conditions such as those located in the 
perianal or vulvar area (Nardelli et al, 2005) may also be complicated by fragrance allergy. 
 
Conclusions 
 This study illustrates that also in our department, fragrance contact allergy is commonly 
observed in patients suffering from contact dermatitis, both in males and in females, and has shown 
a fluctuating trend over the years. Positive patch tests to the fragrance-allergy markers, that is, FM, 
M. pereirae (balsam of Peru), and colophonium in the standard series are frequently associated. The 
hands and face were the most commonly affected body sites, and significant associations were 
found for legs, arms, and axillae. Some fragrance allergens are specifically related to certain lesion 
localizations. Moreover, although HICC and FM II were only more recently introduced in the 
standard series, a significant association was found between HICC and axillae (in females). 
 However, not only the fragrance-allergy markers present or those being introduced in the 
standard series need to be taken into account, but also the products used by the patients, essential 
oils and other individual fragrance allergens as this certainly increases the detection of fragrance 
allergy (data to be published). 
 Special attention to safety assessments must be made for fragranced products and, 
particularly, for those intended for use on potentially traumatized skin, that is, hands, beard region, 
shaved legs, occluded areas or areas of high absorption, that is, eyelids, axillae, and genitals, or in 
chronic dermatitis, that is, stasis dermatitis/leg ulcer patients. 
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Abstract 
 
Background: Chloroatranol and atranol are degradation products of chloroatranorin and atranorin, 
respectively, and have been identified as important contact allergens in oak moss absolute (Evernia 
prunastri). 
Objectives: To investigate whether chemically modified extracts of oak moss produce positive patch 
test reactions in previously sensitized subjects. 
Methods: A sample of oak moss was treated by a polymer-based method to reduce the content of 
the two main allergens, namely atranol and chloroatranol, from 3.4% to less than 75 p.p.m. and 
from 1.8% to less than 25 p.p.m., respectively. Fourteen subjects with positive reactions to oak 
moss from Trolab and/or Chemotechnique were patch tested to this sample, diluted 1% in 
petrolatum. 
Results: The chemically modified sample reacted negatively in six but gave still positive reactions 
in eight subjects, with the same intensity as the commercially available oak moss patch test 
materials. 
Conclusions: Polymer based treatment of oakmoss extract reduces the allergenic elicitation 
potential in previously sensitized individuals only to a minor extent. The residual concentrations of 
atranol and chloroatranol being less than 75 p.p.m. and 25 p.p.m., respectively, are unsafe for the 
consumer. 
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Oak moss absolute, a popular natural extract derived from the lichen Evernia prunastri, is widely 
used in perfumery because of its woody aroma and fixative properties (Larsen et al, 1998; 
Actander, 1960). It has been identified as a major cause of allergic reactions, accounting for at least 
20% of the reactions observed with the Fragrance Mix I (Larsen et al, 1998;Buckley et al, 2000; 
Schnuch et al, 2004). For this reason, oak moss absolute is part of the diagnostic screening test for 
fragrance contact allergy (Larsen et al, 1998). Chloroatranol and atranol have been identified as the 
main allergens in oak moss absolute by a bioassay-guided chemical fractionation procedure. Both 
substances are not found to be significantly present in the natural form of oak moss. However, 
during the production of the fragrance material, they can be formed by decomposition of depsides 
present in the lichen such as chloroatranorin and atranorin, which are non-volatile and odourless 
substances (Bernard et al, 2003). The content of atranol and chloroatranol in cosmetic products 
depends upon the oak moss absolute used, upon the degradation of atranorin and chloroatranorin in 
the product matrix, and, finally, upon the matrix effect in the determination of these molecules 
(Rastogi et al, 2004). 
 It has been found that oak moss absolute contains approximately 2.1% (w/w) of atranol and 
0.9% (w/w) of chloroatranol (Bernard et al, 2003). For this reason, exposure seems to be greater to 
atranol than to chloroatranol in perfumes. Indeed, quantitative exposure to chloroatranol and atranol 
has been studied in some popular perfumes, eaux de parfum and eaux de toilette available on the 
European market. Thirty-one products were analysed by liquid chromatography–electrospray 
ionization tandem mass spectrometry (LC- ESI-MS-MS) for their contents of atranol and 
chloroatranol. The two substances were found in 87% (n = 27) of the products investigated, atranol 
in a median concentration in perfumes of 0.5 p.p.m. and chloroatranol of 0.25 p.p.m., with a 
maximum of 190 p.p.m. and 53 p.p.m., respectively (Rastogi et al 2004; Johansen et al, 2006). In 
2007, Rastogi et al. (Rastogi et al, 2004; Rastogi et al, 2007) observed a significant decrease in the 
frequency of presence of chloroatranol in the products analysed in comparison with the above-
mentioned study. 
 The sensitizing capacity of chloroatranol and atranol, as well as of oak moss absolute, has 
been studied in the local lymph node assay, and all proved to be strong sensitizers. It was shown 
that less chloroatranol was required than atranol to induce sensitization (SCCP, 2004). Moreover, it 
was also shown that chloroatranol was more likely to pro- duce a patch test response than atranol 
when tested in equimolar concentrations in sensitized individuals. The elicitation capacity of 
chloroatranol relative to atranol was 217%, i.e. a factor of 2.2 based on molar concentrations 
(Johansen et al, 2006). The difference in exposure to atranol and chloroatranol may, therefore, 
counterbalance the difference in elicitation capacity with regard to clinical importance. 
 The Scientific Committee on Consumer Products (SCCP), an independent advisory committee 
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to the European Commission, recommended in 2004 that chloroatranol and atranol should not be 
present in any cosmetic product because of their potency as allergens and considered untreated oak 
moss to be unsafe for the consumer (SCCP, 2004). Therefore, an important challenge today for the 
cosmetic industry is to remove selectively the oak moss absolute allergy-causing components in a 
fashion that will not affect most of the other components of the extract neither its olfactive 
properties. 
 To improve the skin tolerance to atranol and choroatranol, Ehret et al. (Ehret et al, 1992) 
described the treatment of oak moss absolute with amino acids such as lysine and leucine, which 
lowered the content of allergenic constituents. The resulting oak moss absolute was tested in 
comparative studies on guinea-pigs and healthy volunteers. The results of the guinea-pig 
maximization test and human repeated insult patch test indicated that, in comparison with the 
commercial test sample, the allergenicity of the new oak moss absolute was considerably reduced. 
However, appropriate clinical studies on individuals with characterized contact allergy to oak moss 
have never been performed, to our knowledge, and are still required to demonstrate the dose–
response characteristics of elicitation reactions with oak moss-treated preparations. 
 An elegant and efficient procedure reported in the literature for the removal of allergenic 
components of some essential oils was based on their binding to an insoluble polymer support 
through a mild coupling reaction (Cheminat et al, 1980, Cheminat, 1981). As an example, the use of 
aminoethyl-polystyrene in ethanol was described to allow the removal of allergenic - methylene--
butyrolactones from costus oil by Michael addition of the polymer nucleophilic ends with the 
electrophilic conjugated system of the lactones. In the course of our studies on allergenic natural 
extracts, we adapted this methodology to oak moss in order to remove sensitizing molecules such as 
aldehydes atranol and chloroatranol. The current clinical study was undertaken to investigate 
whether this chemically modified oak moss absolute, treated by a polymer-based method and 
containing less amounts of chloroatranol and atranol, still produced positive patch test reactions in 
previously sensitized subjects. 
 
Materials and Methods 
 A sample of oak moss absolute was treated by a polymer-based method to reduce the content 
in atranol and chloroatranol, the two main allergens present in oak moss, at the Laboratory of 
Dermatochemistry, University Louis Pasteur, Strasbourg, France. The natural extract was trea- ted 
with a polystyrene derivative having a specific reactivity towards aldehydic chemical functions. 
After treatment, the polymer containing the alde- hydes bound was filtered-off, the solvent of the 
filtrate was removed under reduced pressure, and the remaining product was the polymer-treated 
oak moss absolute (sample A). It was possible to recover afterwards the polymer-bound aldehydes 
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through chemical treatment. Atranol and chloroatranol contents were decreased (sample A) from 
3.4% to less than 75 p.p.m. and from 1.8% to less than 25 p.p.m., respectively (high- performance 
liquid chromatography–ultraviolet measurements). 
From February 2004 until November 2006, 14 patients, 4 males and 10 females (age range 
24–76 years), known to be sensitized to oak moss absolute, were investigated at the Contact Allergy 
Unit in Leuven. They were retested to oak moss absolute from Trolab and Chemotechnique and 
patch tested to sample A, diluted in a 1% concentration in petrolatum. The patches were applied to 
the upper back using either Finn Chamber with filter discs affixed with Scanpor tape or Van 
Der Bend patch test chambers (Van Der Bend, Brielle, the Netherlands) on Micropore TM (3M 
Health Care, Borken, Germany) and fixed with Mefix1 (Mölnlycke Health Care, Göteborg, 
Sweden). 
The patch tested readings were performed according to the international guidelines by the 
International Contact Dermatitis Research Group (Wahlberg, 2001) after 2 days and 4 days, except 
in six subjects who did not want to come back for the second reading, but who were asked to report 
on additional late positive reactions by telephone. 
 
Results 
Table 1 summarizes the patch test results. All 14 subjects had a positive reaction to oak moss 
absolute, from Trolab, Chemotechnique, or both. In six of them, negative reactions to sample A 
were observed: three had negative readings at D2 and D4 and the other three reacted negatively at 
D2 and did not report on additional late positives. Eight subjects reacted to sample A with the same 
intensity as the commercially available oak moss patch test materials. 
 
Table 1. Patch test results at day 2 and day 4 
 
Patient 
Oak moss Trolab 
D2        D4 
Oak moss Chemotechnique 
D2           D4 
Oak moss Sample A 
D2        D4 
Other 
1 +             NR _                NR +             NR* FM I 
2 _              _ _                  + _              NR* FM I 
3 +++        NR +++           NR _              NR* FM I 
4 +?           NR +               NR +             NR FM I, colophonium 
5 +             NR +               NR +             NR FM I 
6 +             NR +                NR _             NR* FM I, colophonium 
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7 +?            +? +                + _              _ FM I 
8 +             + +                _ +?           + FM I 
9 +             ++ +                ++ +            ++ FM I 
10 +             ++ _                  _ +?          ++ FM I 
11 +?            + +?               + +?           + FM I 
12 +             + _                 +? _             _ FM I 
13 _             + _                 _ _             +? FM I, colophonium 
14 _             ++ _                 ++ _             _ FM I 
+?, doubtful reactions; FM I, fragrance mix I; NR, not read. 
* Did not report on additional late positive reactions. 
 
Figures 1 and 2 illustrate the positive patch test reactions observed in patient number 3. In Fig. 2, 
extreme positive reactions with intense erythema, infiltration, and coalescing vesicles to oak moss 
absolute from Trolab and Chemotechnique are visible, whereas the treated oak moss sample A is 
negative. Additionally, the patient also reacted to other components of Fragrance Mix I, i.e. 
isoeugenol and eugenol. 
 
 
 
Fig. 1. Positive patch-test reaction to Fragrance Mix I (subject 3). 
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Fig. 2. Positive patch-test reactions to the ingredients in the same patient, the chemically modified 
sample A (0M010) being negative. 
 
Discussion 
 According to the EU Cosmetics Directive, the maximum authorized concentration of oak 
moss absolute in cosmetic products is 0.1% (Council Directive/EEC, 1976). An oak moss sample 
was found to contain approximately 2.1% atranol and 0.9% chloroatranol (Bernard et al, 2003). 
Considering this as representative of atranol and chloroatranol in different oak moss absolutes 
samples, cosmetic products may contain up to 0.0021% (21 p.p.m.) atranol and 0.0009% (9 p.p.m.) 
chloroatranol. With regard to elicitation, chloroatranol was shown to cause reactions at the p.p.m. 
level (0.0005%, i.e. 5 p.p.m.) by repeated open exposure and at the p.p.b. level on patch testing 
(50% reacted to an extreme low concentration at 0.000015%, i.e. 150 p.p.b.) (Johansen et al, 2003). 
Judged from this elicitation profile, chloroatranol is considered to be the most potent allergen 
present in consumer products today. 
 In 2008, based on new experimental sensitization data on chemically treated and untreated 
oak moss absolute samples, the SCCP was of the opinion that treatment of oak moss absolute at a 
lab- oratory scale was able to reduce the levels of atranol and chloroatranol to less than 2 p.p.m. 
each. Therefore, the levels of these allergens in cosmetic products in which oak moss is used at 
0.1% would be such that the risk of induction and elicitation of allergic reactions to them would be 
low. However, the SCCP still considers that any reduction in elicitation will need to be 
Andrea Nardelli  56
demonstrated by appropriate clinical testing of subjects previously sensitized (SCCP, 2004). 
 In the clinical study presented here, a chemically modified oak moss absolute, by using a 
polystyrene derivative with specific reactivity towards aldehydic chemical functions, was used to 
investigate if it still produced positive patch test reactions in previously sensitized subjects. The 
chemical treatment with the polymer gave a quality of oak moss with a low content of atranol and 
chloroatranol. It was estimated that atranol and chloroatranol contents were decreased from 3.4% to 
less than 75 p.p.m. and from 1.8% to less than 25 p.p.m., respectively. The patch test results 
presented here showed that treated oak moss produced elicitation reactions in 8 of 14 oak moss 
previously sensitized subjects. Therefore, it must be considered that the residual concentrations of 
atranol and chloroatranol being less than 75 p.p.m. and 25 p.p.m., respectively, are still far too high 
to be safe regarding elicitation. 
 However, we did show in a previous study that methyl--orcinol carboxylate, a depside 
degradation product and the most important monoaryl derivative of oak moss from an olfactory 
stand point, was also eliciting a reaction in patients sensitized to oak moss included in the study, 
although to a lower extent compared with atranol and chloroatranol (Bernard et al, 2003). In reality, 
freshly harvested oak moss has no scent. The moss contains various types of depsides, which are 
non-volatile and odourless such as atranorin and chloroatranorin (Ter Heide et al, 1975). The 
characteristic oak moss fragrance is developed after cleavage of the depsides under treatment of the 
oak moss concrete with alcohols to give volatile, scented monoaryl derivatives (Boelens et al, 
1993). As such, the transesterification and decarboxylation of atranorin and chloroatranorin during 
the ethanolic treatment of the moss gives not only atranol and chloroatranol but also methyl--
orcinol carboxylate, which is the major responsible for the characteristic earthy like odour of oak 
moss products (Bernard et al, 2003). The treated oak moss absolute used in this study was obtained 
after a polymer-based treatment that was only specific for the removal of aldehyde derivatives such 
as atranol and chloroatranol. Therefore, methyl--orcinol carboxylate was still present in the tested 
sample A. As this compound was shown to elicit allergy reactions to previously sensitized oak moss 
patients and as it was not removed by the chemical treatment of the moss, it might be also suggested 
that the methodology used for that treatment did not completely eliminate the eliciting potential of 
oak moss absolute, so could also be an extra factor to explain why some patients still elicited 
positive reactions to the treated oak moss. 
 
Conclusions 
We could show that polymer-based treatment of oak moss extract reduces the allergenic elicitation 
potential in previously sensitized individuals only to a minor extent. In view of more recent data 
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and considering elicitation, the major sensitizers atranol and chloroatranol should be eliminated 
almost completely from oak moss absolute in order to be safe for consumers. 
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Abstract 
 
Objectives: To determine which topical pharmaceutical products marketed in Belgium contain 
fragrances and to examine the nature of the fragrance allergens in specific pharmaceutical products 
having caused iatrogenic contact dermatitis. 
Methods: All topical pharmaceutical products marketed in Belgium, that is 3820 products, were 
examined as to their fragrance content as labelled. Data of 18 960 patients investigated for contact 
allergy between 1978 and 2008 were retrieved from our database, including information on the 
nature of the topical pharmaceutical products used, the results of patch tests, and the sensitization 
sources. 
Results: Three hundred and seventy (10%) of 3280 of the topical pharmaceutical products were 
found to contain a total of 66 fragrance substances. Among 3378 patients suffering from iatrogenic 
allergic contact dermatitis, 127 were found to react to 48 specific products, for which 38 different 
fragrance substances gave relevant positive reactions. Women were more affected than men, and 
legs, hands, and face were the most commonly affected body sites. 
Conclusions: Fragrances, the presence of which is in most cases unnecessary, do contribute to 
iatrogenic allergic contact dermatitis. Moreover, sensitized patients have difficulties in avoiding 
their specific allergens because standardized labelling of the ingredients in pharmaceutical products 
is lacking. 
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Contact allergy to fragrances is common, the frequency of which in the general population is 
estimated to be around 1.5% (Denmark, 1.1% and Norway, 1.8%) (Nielsen et al, 1992; Dotterud et 
al, 2007; White et al, 2006) and between 6.5% and 10.4% in contact dermatitis patients (Frosch et 
al, 2005a; Pratt et al, 2004). The real incidence of adverse reactions to topical medicaments is not 
known, and most of the data about prevalence are quite old with a frequency estimated to be 
between 14% and 18% among patients investigated for contact allergy (Brandão et al, 2006). In our 
contact allergy unit, topical pharmaceutical products account for about 33% of all contact allergies, 
the allergenic culprits being active principles, preservatives, vehicles, and also fragrance 
components (Brandão et al 2006, Brandão et al, 2001). 
 Labelling of all pharmaceutical products has been required in Belgium since the end of the 
19th century, that is active principles and also inactive ingredients (Dooms-Goossens et al, 1980). 
Regarding the fragrances, their precise nature or a statement such as ‘perfume’ can be found, either 
on the packaging or on the notice (leaflet). In Europe, such labelling has been required since 1965, 
and only the active ingredients needed to be taken into account (De Greef et al, 1978). The list of 
ingredients to be labelled in 1965 was, however, revised in 2001: additional particulars needed to be 
stated on the outer packaging of medicinal products, such as the list of all excipients in the case of 
injectable products or of topical or eye preparations (EU Directive, 2001). However, there is no 
restriction as to the presence of fragrance allergens nor are the ingredient names standardized. 
 The fragrances present may be natural products, such as essential oils (e.g. orange flower oil 
and lavender oil), resins [e.g. benzoin and balsam of Peru (Myroxylon pereirae)], semisynthetic 
chemicals (produced from isolates through chemical reactions, such as terpineol from pinene and 
hydroxycitronellal from citronellal), and synthetic chemicals (Scheinman, 1996, De Groot et al, 
1997). 
 The importance of fragrance components as allergens in specific topical pharmaceutical 
products has not been reported before. 
The aims of this retrospective study were: 
(1) To determine which and how many topical pharmaceutical products marketed in Belgium 
contain fragrance components. 
(2) To examine the nature of the fragrance allergens in specific pharmaceutical products that have 
caused iatrogenic contact dermatitis. 
 
Materials and Methods 
 
 This was a cross-sectional study for which all data were retrieved from and evaluated with in-
house developed databases in our contact allergy unit (Dooms-Goossens et al, 1980; Goossens et al, 
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1998). The database on topical pharmaceutical products, first developed in 1978, contains 
information on the complete composition (including fragrance ingredients) of 3820 products 
marketed in Belgium (preparations by pharmacists not included) in which the nature of the 
fragrance allergens (as labelled) was examined. An ingredient was considered to be a ‘fragrance’ 
according to its classification as a fragrance or ‘aroma’ by the International Cosmetic Ingredient 
Dictionary and Handbook (Wenninger et al, 2000) (Table 1). 
 
Table 1. Fragrance componentsa identified in 370 topical pharmaceutical products marketed in 
Belgium 
Fragrance components 
N° of topical 
pharmaceutical 
products
Menthol 99 
Lavandula Angustifolia (lavender) Oil (Lavender oil) 68 
Mentha Piperita (Peppermint) Oil (Peppermint oil) 54 
“Perfume” 51 
Camphor 48 
Eucalyptol (Cineole/Eucalyptol) 47 
Rose Flower Oil (Rose oil) 33 
Citrus Medica Limonum (Lemon) Peel oil (Lemon oil) 24 
Cymbopogon Nardus (Citronella) Oil (Citronella oil) 24 
Pinus Sylvestris Leaf Oil (Pine needle oil) 21 
Geranium Maculatum oil (Geranium oil) 20 
Eucalyptus Globulus Leaf Oil (Eucalyptus oil) 17 
Citrus Aurantium Bergamia (Bergamot) Fruit Oil (Bergamot Fruit oil) 17 
Eugenol 15 
Thymus Vulgaris (Thyme) Oil (Thyme oil) 14 
Citrus Aurantium Dulcis (Orange) Flower Oil (Orange flower oil) 13 
Myroxylon Pereirae (Balsam Peru) resin (Balsam peru) 13 
Turpentine (Turpentine oil) 12 
Rosmarinus Officinalis (Rosemary) Leaf Oil (Rosemary oil) 11 
Illicium Verum (Anise) Oil (Anise oil) 11 
Styrax Benzoin Gum (Benzoin) 10 
Thymol 9 
Colophonium 9 
Benzyl alcohol 9 
Anethole (Anethol) 9 
Vanillin 8 
Terpineol 7 
Myristica Fragrans (Nutmeg) Kernel Oil (Nutmeg oil) 6 
Musk Ketone 6 
Linalool 6 
Citrus Aurantium Amara (bitter orange) Oil (Neroli oil or Petitgrain Oil Organic) 6 
Benzyl acetate 6 
Melaleuca Quinquenervia oil (Niaouli oil) 5 
Linalyl acetate 5 
Hydroxycitronellal 5 
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Dihydrocoumarin 5 
Cinnamyl alcohol 5 
Mentha Viridis (Spearmint) Leaf Oil (Spearmint oil) 4 
Melaleuca Leucadendron Cajaputi Oil (Cajeput oil) 4 
Benzyl benzoate 4 
Melaleuca Leucadendron Cajaputi Oil (Cajeput oil) 4 
Origanum Majorana Leaf oil (Sweet marjoram oil) 3 
Melissa Officinalis (Balm Mint) Leaf Oil (Balm mint oil) 3 
Citrus Nobilis (Mandarin Orange) Peel oil (Mandarin oil) 3 
Isoamyl Acetate (Isoamyl ethanoate) 3 
Cupressus Sempervirens Oil (Cypress oil) 3 
Cinnamomum Cassia Leaf (cinnamon) Oil  (Cinnamon oil) 3 
Cedrus Atlantica (Cedarwood) Bark Oil (Cedarwood oil) 3 
Shorea Robusta Resin (Damar) 2 
Cymbopongon Schoenanthus oil (Lemongrass oil) 2 
Laurus Nobilis oil (Laurel oil) 2 
Foeniculum vulgare (Fennel) oil (Fennel oil) 2 
Coriandrum Sativum (Coriander) Fruit Oil (Coriander oil) 2 
Benzyl cinammate 2 
Cinnamal 1 
Melaleuca Alternifolia (tea tree) Leaf Oil (Tea tree oil) 1 
Jasminum Officinale (jasmine) Oil (Jasmine oil) 1 
Sassafras Officinale Root Oil (Sassafras oil) 1 
Santalum Album (Sandalwood) Oil (Sandalwood oil) 1 
Hyssopus Officinalis Leaf oil (Oil of hyssop) 1 
Dipentene (Limonene) 1 
Heliotropine (Piperanol) 1 
Canarium Luzonicum Gum Oil (Canarium Luzonicum- Elemi) 1 
Ocimum Basilicum (Basil) oil (Basil oil) 1 
Anise alcohol 1 
Amyl Cinnamal 1 
aThe fragrance components are named here with the International Nomenclature of Cosmetic 
Ingredients (which is not the case on the labels, on which many different names for the same 
components could be used) as well as the technical/ trade name in bracket.  
 
 The patient database contains information (including sex, localization of the lesions, the 
topical pharmaceutical products used, the results of patch tests, and the sensitization sources) of 18 
960 patients investigated for contact allergy between January 1978 and June 2008. They were patch 
tested with the European baseline patch test series (Trolab, Hermal, Reinbeck, Germany), additional 
series, and individual substances when indicated. In order to detect the allergenic culprits in patients 
suspected of iatrogenic contact dermatitis, whenever possible, the topical pharmaceutical products 
used along with their ingredients were tested as well. The subjects included in this study were those 
who presented with iatrogenic contact dermatitis from a specific pharmaceutical product and for 
whom a positive reaction was found to a fragrance allergen present. 
 The patch tests were administered with Van der Ben TM patch-test chambers (Van der Bend, 
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Brielle, the Netherlands), applied on the back with MicroporeTM (3M Health Care, Borken, 
Germany), and fixed with Fixomull (Beiersdorf AG, Hamburg, Germany) and later on with 
Mefix1 (Molnlycke Health Care, Goteborg, Sweden) as adhesive tape. The patch test readings were 
per- formed according to the international guidelines by the International Contact Dermatitis 
Research Group (Wahlberg, 2001) after 2, 3 (exceptionally), and 4 days and sometimes later. 
 
Results 
 
 A total of 18 960 patients were investigated for contact allergy, that is 12 419 (65.5%) women 
and 6541 (34.5%) men, for whom the MOAHLFA index (Schnuch et al, 1997; Uter et al, 2008) 
was: M (male), 34.5%; O (occupational dermatitis), 19.7%; A (atopic dermatitis), 22.9%; H (hand 
dermatitis), 40.2%; L (leg dermatitis), 5%; F (face dermatitis), 32.4%; and A (40 years and older), 
43.7%. At least one of the allergens tested produced a positive reaction in 10 249 (54%) patients, 
that is 6103 (60%) women and 4146 (40%) men. Of 10 249, 3378 (33%) suffered from iatrogenic 
contact dermatitis, that is 2268 (67%) women and 1110 (33%) men. One hundred and twenty-seven 
patients, that is 92 (72%) women and 35 (28%) men, reacted to 48 specific topical pharmaceutical 
products in which fragrance components were identified as relevant allergens. Legs (n 57), hands 
(n 39), and face (n 28) were the most commonly affected body sites in these patients, particularly 
in women. 
 We identified 66 different fragrance components (Table 1) in 370 (10% of the total) topical 
pharmaceutical products marketed in Belgium. Table 2 lists the nature of 48 specific products that 
have caused iatrogenic contact dermatitis in 127 patients, along with the nature of the 38 different 
fragrance components these products contain. These are products with wound healing, antiseptic or 
antimicrobial properties, non-steroidal anti- inflammatory drugs (NSAIDs), antihaemorrhoidal 
preparations, and even corticosteroid-containing medications [e.g. Mycolog (Triadcortyl in the 
UK) (Sanofi-Aventis, Diegem, Belgium), Scheriproct and Ultralan (both from Schering, 
Diegem, Belgium)]. So-called parapharmaceutical products, that is products not officially registered 
as pharmaceutical products, were excluded from this list. The fragrance allergens, for which the 
presence was all or not confirmed, but that produced positive patch test results in this population, 
along with the corresponding literature references for each compound, are listed in Table 3. 
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Table 2. The 48 fragrance-containing topical pharmaceutical products marketed in Belgium, found 
to be responsible for iatrogenic allergic contact dermatitis in 127 patients, along with their 
pharmacologic activity and the fragrance ingredients presenta 
Topical 
Pharmaceutical 
Product (n= nr. of 
pt. reacting) 
Company Application Fragrance ingredients 
Mycolog (cream)b 
(n= 34) 
Sanofi-Aventis, 
Diegem 
Antibiotic-
Corticosteroid “Perfume” 
Fastum (gel) (n= 19) Menarini, Zaventem Anti-inflammatory (NSAID) Lavender oil, neroli oil 
Flexium (cream) (n= 
9) Melisana, Brussels 
Anti-inflammatory 
(NSAID) 
Benzyl alcohol, eucalyptus oil, 
pine needle oil 
Dermophil indien 
(ointment) (n= 5) Couvreur, Brussels Wound healing Myroxylon pereirae, rose oil 
Hac (solution) (n= 5) 
SSL Healthcare 
Belgium, Grand-
Bigard 
Antiseptic-
disinfectant Benzyl benzoate, terpineol 
Cicatrisan (ointment) 
(n= 4) Unda, Brussels Wound healing Myroxylon pereirae 
Calendula (ointment) 
(n= 4) Unda, Brussels Wound healing Rose oil 
Homeoplasmine 
(ointment) (n= 3) Unda, Brussels Wound healing Benzoin, benzyl alcohol 
Newderm (ointment) 
(n= 3) Wolfs, Sint-Niklaas Wound healing Geranium oil 
Polyseptol (ointment) 
(n= 3) Qualiphar, Bornem Antibiotic Bergamot fruit oil, geranium oil 
Borostyrol (solution) 
(n= 2) A.C.P., Brussels Wound healing 
Benzoin, bergamot fruit oil, 
menthol, thymol 
Phenergan (cream) 
(n= 2) 
Sanofi-Aventis, 
Diegem Antihistaminic Lavender oil 
Reparil (gel) (n= 2) Madaus, Brussels Anti-inflammatory, Vascular disorders Lavender oil, neroli oil 
Madecassol (cream) 
(n= 2) Bayer, Brussels Wound healing Geranium oil, lavender oil 
Anusol (ointment) 
(n= 2) 
Pfizer Consumer 
Health, Brussels Anti-hemorrhoids Myroxylon pereirae 
Hibitane (cream)  
(n= 2) 
SSL Healthcare 
Belgium, Grand-
Bigard 
Antiseptic-
disinfectant Pine needle oil 
Oxyplastine 
(ointment) (n= 1) 
Bournonville 
Pharma, Brussels Wound healing Myroxylon pereirae 
Murazyme 
(ointment) (n= 1) 
Grünenthal, Sint-
Stevens-Woluwe Wound healing Lavender oil 
Biogaze HN 
(bandage) (n= 1) 
OJG Cons Care, Sint-
Martens-Latem Wound healing Niaouli oil 
Vitamorrhuine 
(ointment)* (n= 1) PCB Wound healing Bergamot fruit oil, lavender oil 
Vegebom (ointment) 
(n= 1) 
Bournonville 
Pharma, Brussels Wound healing 
Cajeput oil, cedarwood oil, 
laurel oil, nutmeg oil, turpentine 
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oil 
Groene Duivel 
(plaster) (n= 1) Colin, Blegny Wound healing Colophonium, turpentine 
Reumatrix (plaster) 
(n= 1) 
Beiersdorf, 
Anderlecht Wound healing Colophonium 
Baume Contre 
Brulures (ointment)* 
(n= 1) 
Qualiphar, Bornem Wound healing Myroxylon pereirae 
Advantan (cream) 
(n= 1) Schering, Diegem Corticosteroid Benzyl alcohol 
Amicla (cream)  
(n= 1) ERFA, Etterbeek Corticosteroid Benzyl alcohol 
Dermaspray 
(solution) (n= 1) Roche, Anderlecht 
Antiseptic-
disinfectant Benzyl alcohol 
Neo-Sabenyl 
(solution) (n= 1) Qualiphar, Bornem 
Antiseptic-
disinfectant Lavender oil 
Dettol (solution) 
 (n= 1) 
Reckitt Benckiser, 
Brussels 
Antiseptic-
disinfectant “Perfume”, terpineol 
Reflex (gel) (n= 1) Boots, Louvain la Neuve 
Anti-inflammatory 
(NSAID) Benzyl alcohol, menthol 
Nifluril (ointment) 
(n= 1) 
Bristol-Myers Squibb 
Belgium, Waterloo 
Anti-inflammatory 
(NSAID) “Perfume” 
Lotriderm (cream) 
(n= 1) 
Schering Plough, 
Brussels Anti-mycosis Benzyl alcohol 
Mycospor (cream) 
(n= 1) Bayer, Brussels Anti-mycosis Benzyl alcohol 
Pevaryl (cream) 
 (n= 1) 
Janssen-Cilag, 
Berchem Anti-mycosis Rose oil 
Chloramphenicol 
(cream) (n= 1) SKF-Rit, Rixensart Antibiotic Neroli oil 
Sarnol (lotion) (n= 1) Stiefel, Herverlee Anti-pruritus/Analgesic Camphor, menthol, “perfume” 
Vicks Vaporub  
(n= 1) 
Procter & Gamble, 
Stombeek-Bever 
To inhale (to relieve 
symptoms of 
bronchitis, sinusitis, 
etc.) 
Camphor, eucalyptus oil, 
menthol, nutmeg oil, thymol, 
turpentine 
Duofilm (solution) 
(n= 1) Stiefel, Heverlee Keratolytic Colophonium 
Scheriproct 
(ointment) (n= 1) Schering, Diegem 
Analgetic, 
antinflammatory Cypress oil 
Caladryl (ointment) 
(n= 1) 
Omega Pharma, 
Nazareth Anti-pruritus Lavender oil 
Benzoeoplossing 
(solution)c (n= 9) ABL Degreaser Benzoin, benzyl alcohol, rose oil 
Maturosan 
(ointment)c (n= 4) Sam Wound healing 
Benzoin, benzyl alcohol, elemi 
resin, turpentine, turpentine oil 
Madecassol 
(ointment)c (n= 3) 
Laroche Navarron, 
Brussels Wound healing Geranium oil, lavender oil 
Pyal (ointment)c(n= 
3) Sanico, Turnhout Antibiotic Bergamot fruit oil, lavender oil 
Oxyplastine 
(ointment)c (n= 2) Promedy Wound healing 
Geranium oil, lemongrass oil, 
myroxylon pereirae, origanum 
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oil, thyme oil 
 
Ultralan Vet Gras 
(ointment)c(n= 1) Schering, Diegem Corticosteroid 
Bergamot fruit oil, cinnamyl 
alcohol, citronella oil, piperonal, 
hydroxycitronellal, ionone, 
lavender oil, linalool, musk 
ketone, neroli oil 
Desinfecterende en 
helende zalf 
(ointment)c (n= 1) 
Unda, Brussels Antiseptic-disinfectant Myroxylon pereirae 
Inhalene (solution)c 
(n= 1) Alcon, Breendonk 
Cold symptoms, 
laryngitis, sinusitis 
Cajeput Oil, cypress oil, 
eucalyptol, eucalyptus oil, musk 
ketone, lavender oil, peppermint 
oil, pine needle oil 
a During the period 1978-2008, the names of the manufacturers or the companies marketing these 
topical pharmaceutical products, as well as the content of the products may have changed over the 
years. 
b Mycolog® cream is marketed in the U.K. as Triadcortyl®. 
c Some of them are no longer commercially available, hence no companies in Belgium anymore. 
 
Table 3. The fragrance allergens identified in 127 patients reacting to the 48 specific topical 
pharmaceutical products 
Allergens PC PNC Litertature references 
Fragrance-mix I  36 51 26, 28, 42, 63, 71-75 
Cinnamyl Alcohol  2 4 64, 71,73 
Cinnamal 2 3  
Geraniola  4 2 74-77, 80 
Hydroxycitronellala  3  64 
Oak moss (Evernia prunastri)a  10  
Eugenola  4 2 81 
Iso-eugenola  3 3  
Fragrance Mix II  2 1  
Citrala 1 1  
Citronellola  2   
Myroxylon Pereirae Resin (balsam of Peru) 21 38 25-28, 42, 57 
Colophonium  7 14 42 
Essential Oils   11, 12 
Lavender Oil  24 2 12, 48, 75, 78 
Neroli Oil 14  48, 12 
Eucalyptus Oil 10  12 
Cananga Odorata Flower (ylang ylang) Oil  2 12 
Cinnamon Oil  1 48 
Jasmine Oil  1 11, 12 
Geranium Oil  12  11, 12 
Laurel Oil 2  12, 53-55 
Niaouli Oil  2 3 
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Pine Needle Oil 4  32, 35 
Tea Tree Oil 2   
Lemon Oil  1  
Rose Oil 5   
Other allergens    
Perfume (Mycolog®) 34  23, 24, 64, 79 
Perfume (Nifuril®) 1   
Amyl Cinnamic Alcohola 2 1  
Thymol 1   
Camphor 2   
Limonene 7 2  
Tree moss (Evernia furfuracea)  1  
Styrax Benzoin Gum (Benzoin) 19  60, 61 
Benzyl Alcohol 5  49, 58, 64 
Benzyl Benzoate 1   
Terpineol 5 1 34 
Turpentine  2   
FM I, fragrance mix I; FM II, fragrance mix II; PC, presence confirmed in the causal 
pharmaceutical product; PNC, presence not confirmed. 
a These allergens were not listed in Table 1 since they were tested due to their presence in FM I or 
in FM II, or in Mycolog® “perfume”. However, all patients were not tested with all individual 
components. 
 
 With regard to the fragrance allergens identified among the 127 patients, fragrance mix I (FM 
I) [containing cinnamyl alcohol, cinnamal, eugenol, amyl cinnamal, hydroxycitronellal, geraniol, 
iso- eugenol, and Evernia prunastri (oakmoss) absolute] was the most frequent allergen found in 
the European baseline patch test series, that is 87 reactions (Table 3), followed by M. pereirae with 
59 positive reactions, both reacting concomitantly in 40 cases. To a lesser extent, colophonium was 
found with 21 reactions, reacting concomitantly to FM I and M. pereirae in 11 cases and with FM I 
alone in 4 more cases. 
 Since 2005, a mixture of six additional fragrance materials has been available for introduction 
into the baseline series, that is fragrance mix II (FM II) (containing hydroxyisohexyl 3-cyclo- 
hexene carboxaldehyde, citral, citronellol, farnesol, coumarin, and hexyl cinnamal) (Frosch et al, 
2005a; Frosch et al, 2005b), for which we detected three relevant positive reactions. Two patients 
reacted to citronellol, and the third patient reacted to farnesol, for which no relevant explanation 
was found, and to eucalyptus oil (cf. below) present in Flexium gel (Melisana, Brussels, 
Belgium). All three also reacted to FM I, one of whom to cinnamyl alcohol present in it. 
 Forty-five patients presented with 82 reactions to one or more essential oils (Table 3); seven 
of them did not react to FM I, M. pereirae, or colophonium. In addition, in those subjects who were 
tested with some of the individual ingredients of essential oils, we found following positive 
reactions: three to (oxidized) limonene in patients positive to lavender oil and two to geraniol in 
patients reacting to geranium oil; of five patients reacting to rose oil, one had a positive reaction to 
benzyl alcohol, one to citronellol, one to limonene, and one to geraniol. The reactions to citronellol 
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(as a component of FM II, cf. above) were relevant too for contact allergy to rose and geranium oil, 
present in Calendula1 ointment (Unda, Brussels, Belgium) and Polyseptol ointment (Qualiphar, 
Bornem, Belgium), respectively. 
There were 34 patients who reacted to the perfume present in Mycolog cream. According to 
data obtained from the company, this perfume contains 28 ingredients, among which one 
(hydroxycitronellal) and three (citral, citronellol, and coumarin) are also present in FM I and FM II, 
respectively. Not all patients reacting to this perfume were tested with the fragrance mixes or with 
other fragrance ingredients, but of the six tested, one presented with a positive reaction to citral, 
three to amylcinnamal, two to limonene, and one to benzyl alcohol. Two subjects also reacted to 
lavender oil, which, besides limonene (not tested in these cases), might share also other common 
ingredients with lavandin oil (Lavandula Hybrida) present in Mycolog cream. 
 We found 19 patients with positive reactions to benzoin, 7 of them because of a degreasing 
solution, 5 to wound healing preparations, and 7 to an ointment preparation against fissures. Of 19, 
9 presented simultaneous reactions to both FM I and M. Pereirae and another 4 to FMI, M. 
pereirae, and colophonium. 
 Simultaneous reactions to M. pereirae and propolis were found in 5 patients and to the 
fragrance components of FM I and M. pereirae (one of them also to colophonium) and Compositae 
mix (Trolab, Hermal) in 7 patients, of whom 6 reacted to arnica and 2 to sesquiterpe-lactone mix. 
 If only the baseline series had been tested, fragrance allergy would have been missed in 24 of 
127 (19%) patients reacting to the 48 responsible products. They did react to perfume, terpineol, 
geranium oil, lavender oil, benzoin, pine needle oil, laurel oil, bitter orange oil, rose oil, laurel oil 
(oxidized), limonene, or thymol. 
 Figs 1 and 2 illustrate allergic contact dermatitis from HAC solution (SSL Healthcare, 
Groot-Bijgaarden, Belgium) and the positive test to its ingredient a-terpineol. Fig. 3 shows residual 
permanent hyperpigmentation as a complication of allergic contact dermatitis from benzoin in a 
degreasing solvent applied under a cast. Besides benzoin, the patient also reacted to FM I and M. 
pereirae. 
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Fig. 1. Allergic contact dermatitis from terpineol in HAC® solution (SSL Healthcare, Groot-
Bijgaarden, Belgium). 
 
 
Fig. 2. Positive reaction to terpineol 5% petrolatum in the same patient. 
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Fig. 3. Residual permanent hyperpigmentation as a complication of allergic contact dermatitis from 
benzoin tincture in a degreasing solvent applied under a cast. 
 
Discussion 
 Most patients reacting to 48 specific fragrance-containing topical pharmaceutical products 
reacted to FM I, followed by M. pereirae, and colophonium, the fragrance-allergy markers present 
in the European baseline patch test series. Reactions to them were often associated (Wohrl et al, 
2001; Nardelli et al, 2008; Thyssen et al, 2008; Hjorth 1961; Larsen, 1977), which is explained by 
the presence of similar components. In 1977, Larsen even introduced FM I partly based on positive 
patch test results obtained with the fragrance components of Mycolog perfume (Larsen, 1977; 
Larsen, 1985) to detect fragrance allergy. 
 Allergic contact dermatitis from M. pereirae in Dermophil Indien (Couvreur, Brussels, 
Belgium) was described by Foussereau (Foussereau, 1975) in 1975, and recent studies (Avalos-
Peralta et al, 2005; Machet et al, 2004; Green et al, 2007) indicate that the increased incidence of 
sensitization to M. pereirae observed is mainly because of fragrances present in topical medications 
for wound-healing or antimicrobial effects (Hasan et al, 2005; Lindberg et al, 2007). Most 
ingredients of M. pereirae are present in or related to other allergenic fragrance materials, for 
example three of them being present in FM I, that is cinnamyl alcohol, cinnamal, and eugenol. 
Furthermore, propolis, a resinous substance collected by bees (Martindale, 1999), to which anti-
inflammatory and antimicrobial properties are attributed, also shares several minor sensitizers with 
M. pereirae, which explains the concomitant reactions; according to Wohrl et al. (Wohrl et al, 
2001), it is also a helpful indicator for fragrance allergy. 
 Colophonium may cross-react or co-react with other fragrance allergens (Saap et al, 2004; 
Roesyanto et al, 1990; Malten et al, 1976; Iorizzo et al, 2000; Johansen et al, 2002; Lepoittevin et 
al, 2000) that also contain oxidized terpenes (Karlberg et al 1988; Karlberg, 1991); it is mostly 
found as an allergen in classical adhesive tapes (not taken into account in this study) but is also used 
as a vehicle component in wart medications, surgical paints (Reichert-Penetrat et al, 2001), and 
Chinese herbal medicine (Li, 1995; Chen et al, 2003), the latter of which two such cases were 
included here. Such medications generally contain more fragrance allergens and plant extracts than 
topical pharmaceutical products sold in Europe (Chen et al, 2003). Moreover, modified 
colophonium is also present in wound dressings. 
 Essential oils are mainly constituted of terpenes such as a-pinene and b-pinene, citral, 
geraniol, linalool, citronellal, hydroxycitronellal, and limonene but also of other organic chemical 
com- pounds, including aromatics, aliphatics, alicyclics and heterocyclics. It has been shown that 
terpenes are not allergenic themselves but that their oxidation products are the strongest allergens 
Andrea Nardelli  71
formed being mainly hydroperoxides (Matura et al, 2003; Sköld et al, 2002; Sköld et al, 2004; 
Sköld et al, 2008). Although patch test material of the oxidized forms of linalool and limonene are 
not commercially available yet (Sköld et al, 2002; Sköld et al, 2004), we did test with aged 
materials and thus obtained positive patch test results. As shown in Table 2, essential oils are 
present in several pharmaceutical topical products, particularly in those that have been marketed 
several decades ago. Unfortunately, they are also found in more recently marketed preparations 
such as NSAIDs. In a recent study performed in our department (Devleeschouwer et al, 2008), 10 
of 40 patients with positive photo-patch tests to Fastum (Menarini, Zaventem, Belgium) presented 
with a contact allergy to the essential oils present in them. Moreover, 22 of 40 reacted to FM I 
and/or M. pereirae but not to the essential oils contained in these products. In agreement with the 
literature, fragrance allergy, and cinnamyl alcohol in particular, is indeed often related to 
photocontact allergy to ketoprofen, the reason for which is not clear (Matthieu et al, 2004; Girardin 
et al, 2006). 
 Because of their pharmacological properties, such as antiseptic, analgesic, or anti-
inflammatory effects, essential oils and their ingredients are often used for medical instead of 
cosmetic reasons. Currently, these substances are frequently found in aromatherapy (Cockayne et 
al, 1997; Trattner et al, 2008; Keane et al, 2000) and are applied directly to the skin for the 
treatment of, for example, arthritis (Ozden et al, 2001; Onder et al, 2003), muscular pains (Adisen 
et al, 2007), etc. In dentistry, for example, eugenol, an important chemical constituent of clove oil, 
is widely used because of its antiseptic properties (Estlander et al, 2006). A Swedish study has 
reported that even M. pereirae, which also contains eugenol, is used in dental cement and indicated 
that the oral mucosa might also be a sensitization site (Svedman et al, 2007). 
 Benzyl alcohol (Curry et al, 2005; Sestini et al, 2004) is present in M. pereirae at 1–2% 
concentration and is an aromatic preservative agent that also has anaesthetic, antipruritic, and 
viscosity-decreasing properties (Curry et al, 2005; Sestini et al, 2004; Hausen et al, 2001). Despite 
its widespread use, sensitization to this allergen is considered rare but has been responsible for 
allergic contact dermatitis from antibacterial and antimycotic creams, topical corticosteroids, 
sunscreens, analgesic sprays, and sclerosing agents (Curry et al, 2005; Sestini et al, 2004). 
 Benzoin is a balsamic resin obtained from Styrax benzoin Dryander and other species of 
Styrax (Faro. Styraceae). The tincture is used (Lakshmi et al, 2006; Scardamaglia et al, 2003) to 
enhance the adhesive properties of tape and bandages, as an antiseptic, and also as a solvent for 
drugs, for example in podophyllin tincture, used in the treatment of venereal warts (Lakshmi et al, 
2006). The main constituents of benzoin are resin, benzoic acid, and cinnamic acids and their esters. 
In addition, traces of vanillin, benzaldehyde, styrol, and styracin are also present (Lakshmi et al, 
2006; Scardamaglia et al, 2003). Cross-reaction between benzoin and similar allergens (FM I, M. 
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pereirae, colophonium, and tea tree oil) have been reported (Lakshmi et al, 2006; Scardamaglia et 
al, 2003). 
 The observation of simultaneous reactions to fragrances and Compositae plant extracts 
(sesquiterpene lactones) can be explained by the common presence of terpenes (Paulsen et al, 2005; 
Paulsen et al, 2002). 
 In agreement with the literature, multiple sensitization to several fragrances was also observed 
in this study population, and the risk becoming higher because of the frequent application of topical 
pharmaceutical products also in chronic dermatological conditions in which the skin barrier is 
damaged: leg ulcer patients, patients with dermatitis on the hands (also direct contact when 
applying the products on the skin), patients with chronic facial dermatitis such as seborrhoeic or 
atopic dermatitis (Avalos-Peralta et al, 2005; Machet et al, 2004; Uter et al, 2002; Zmudzinska et 
al, 2006; Lim et al, 2007). 
 Since 1997, all cosmetic ingredients have been labelled in a uniform manner with the 
International Nomenclature of Cosmetic Ingredients name, except for fragrance. Since 2005, the EU 
has also required that 26 important fragrance allergens be labelled specifically (EU Directive, 
2003). Moreover, restrictions have been made on the use concentrations of certain allergens, for 
example isoeugenol (Rastogi et al, 2008). Besides EU regulations, the International Fragrance 
Research Association gives advice as to the use of certain fragrance allergens by the perfume 
industry; for example, the use of crude M. pereirae in cosmetics has been banned since 1982 (Api et 
al, 2006) (albeit that the extracts or distillates are not necessarily less allergenic). In contrast, in 
topical pharmaceutical products in Europe, there is no legislation regarding such labelling: the 
nomenclature of the ingredients has not been standardized (Degreef et al, 1978), and several 
synonyms may appear on the label or on the notice. As to the presence of fragrance allergens, no 
restrictions have been made either. 
 
Conclusions 
 
 The fragrance-allergy markers in the baseline series did pick up most of the patients sensitized 
to fragrance allergens present in the 48 specific topical pharmaceutical products to which they 
reacted. However, extended patch testing with the products used by the patient, along with the 
ingredients, is also needed because one fifth of them only reacted positively to an essential oil or to 
another fragrance allergen present. The possibility of testing all the components of a commercial 
product depends, of course, on the manufacturer’s goodwill to provide all ingredients. 
 Because topical pharmaceutical products are applied on more vulnerable, and often diseased 
skin (wounds, leg ulcers, eczema, etc.), they thus constitute another important source of fragrance 
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sensitization, which predisposes the patients to develop multiple sensitivities and to react also to 
fragrance-containing cosmetics (and other fragranced materials). Besides their use as a 
pharmacologically active ingredient in some cases, the use of fragrances in topical pharmaceutical 
products is unnecessary. In agreement with other authors (Schliemann et al, 2006; Garioch et al, 
1989), we also urge for better legislative measures and a standardized labelling of all ingredients of 
such products. 
  
Andrea Nardelli  74
 
 
 
 
 
 
 
 
 
Chapter 8 
 
 
 
Fragrance allergens in ‘specific’ cosmetic products 
 
 
Andrea Nardelli, Jacques Drieghe, Lieve Claes, Lies Boey and An Goossens 
 
Contact Allergy Unit, Department of Dermatology, University Hospitals Leuven, Katholieke 
Universiteit Leuven 
 
 
 
 
 
 
 
 
 
 
 
 
 Contact Dermatitis 2011, 64, 212–219 
Andrea Nardelli  75
Summary 
Background. Together with preservative agents, fragrance components are the most important 
sensitizing culprits in cosmetic products. 
Objectives. To identify the nature of the fragrance ingredients responsible for allergic contact 
dermatitis (ACD) from specific cosmetic products. 
Methods. Between 2000 and 2009, positive patch test reactions or positive usage tests with the 
patients own cosmetic products, were recorded using a standardised form. Results. Of the 806 
cosmetic records, corresponding to 485 patient files, 344 concerned reactions to fragrance 
ingredients that according to the label were present (‘Presence Confirmed’ [PC n = 301]) or 
suspected to be present (‘Presence Not Confirmed’ [PNC n = 376]) in the causal cosmetic products 
used, which belonged to 15 different categories, toilet waters/fine perfumes being the most frequent. 
Geraniol in fragrance mix I (FM I) and hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC) in 
FM II were the most frequent PC, and together with hydroxycitronellal and Evernia prunastri (oak 
moss) the most frequent PNC ingredients in the causal cosmetic products. Limonene was the most 
frequent PC confirmed fragrance allergen. 
Conclusions. This study not only underlines the usefulness of fragrance-ingredient labelling in order 
to identify the causal allergen(s) present in specific cosmetic products, but may also provide 
information on trends in the actual use of sensitizing fragrance ingredients in them. 
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Introduction  
 Together with preservatives, fragrance chemicals are the most important sensitizers in 
cosmetic products (Wetter et al, 2010). Notwithstanding the many publications on this subject, the 
specific fragrance allergens contained in the different types of cosmetic products causing allergic 
contact dermatitis (ACD) have been infrequently identified (Goossens, 2006). 
 In the United States, cosmetic ingredients have been listed on the packaging of cosmetic 
products for over 20 years, but in Europe this has been done only since 1997, with fragrance 
components requiring to be labelled as ‘perfume’ or ‘aroma’ (EU Directive, 2003) (the word 
‘fragrance’ has not been mentioned in the legislation, although is frequently used on the packaging 
of cosmetic products). A later amendment to the European Cosmetics Directive in March 2005 
stated that manufacturers had to individually label 26 recognized fragrance sensitizers (EU 
Directive, 2003), using the International Nomenclature Cosmetic Ingredient (INCI) name, which is 
based on the US Cosmetic, Toiletry, and Fragrance Association nomenclature (Wenninger et al, 
2000). Labelling is required if such a component is present at ≥10 ppm in leave-on cosmetic 
products or ≥100 ppm in rinse-off cosmetic products. 
 The present study sought to identify the nature of fragrance allergens responsible for ACD 
caused by specific cosmetic products. It does not, of course, reflect the most frequent fragrance 
allergens encountered in the total population tested. 
 
Materials and Methods 
 This was a cross-sectional study, for which all data were retrieved from, and evaluated with, 
databases developed in-house in our department (Goossens et al, 1998). 
 Between January 2000 and September 2009, positive patch test reactions or positive usage test 
results with the patients’ own cosmetic products, as well as allergic 
contact reactions to specific cosmetic ingredients, were recorded with the use of a standardized 
form (Fig. 1). When, according to the label, the ‘specific’ allergens to which the patients were 
sensitized were identified in the causal cosmetic product used, the allergens were indicated with 
‘presence confirmed’ (PC), and for ‘specific’ allergens that were only suspected to be present, the 
indication ‘presence not confirmed’ (PNC) was used. In the latter case, the patients had not kept the 
packaging with the label, and, in the case of fragrances, were using products for which only the 
term ‘fragrance’ or ‘perfume’ had been mentioned (before 2005). A reaction to a specific fragrance 
allergen shown to be present in the causal product did not imply, of course, that only this allergen 
was held to be responsible for the dermatitis in cases where the patient reacted to another ingredient 
as well. 
 All subjects had been tested with the European baseline series containing fragrance mix I (FM 
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I), Myroxylon pereirae, colophonium, and, from 2005 onwards, fragrance mix II (FM II) (Bruze et 
al, 2008). The patients reacting to FM I and FM II were, in most cases, tested with the individual 
ingredients, and some of them were also tested with other fragrance components. 
 All patch test results had been obtained with Van der Bendpatch test chambers (Van der 
Bend, Brielle, The Netherlands) applied on the back with Micropore(3M Health Care, Borken, 
Germany), and fixed with Mefix(Mölnlycke Healt Care, Göteborg, Sweden) as adhesive tape. 
The patch test readings were performed according to the international guidelines of the International 
Contact Dermatitis Research Group (Wahlberg, 2001) after 2 days, 3 days (exceptionally), and 4 
days, and sometimes also later. Sometimes, repeated open application tests or usage tests had been 
performed if a cosmetic product that remained negative on patch testing was suspected to be 
responsible for the dermatitis that the patient had presented with. 
 
Fig. 1. Standardized form used to collect information on specific causal cosmetic products. 
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Results 
 Of the 806 records, corresponding to 485 patient files (some reacted to several cosmetic 
products), 344 concerned reactions to FM I and FM II, and/or to 28 fragrance ingredients, which, 
according to the label, were present in the causal cosmetic products used (PC, n= 301), or 
concerned an ingredient suspected to be present (PNC, n=376). Several fragrance allergens often 
accounted for reactions to one particular cosmetic product. A slight majority of the fragrance 
allergens that were only suspected to be present were found in the years 2000–2005, as the 26 
individual ingredients were not required to be labelled then, that is, 219 (58%) of 376 PNC 
ingredients. However, many patients had still continued to use ‘older’ products afterwards 
(especially in the case of fine fragrances) or had not always kept the packaging. 
 Table1 gives the total number of PC and PNC ingredients of the fragrance allergens, as well 
as their presence in the different types of cosmetic product found to be responsible for ACD in the 
patients investigated. 
 
Table 1.  Number of ‘presence confirmed’ (PC) and ‘presence not confirmed’ (PNC) fragrance 
allergens in ‘specific’ causal cosmetic products to which the patients studied reacted positively  
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With regard to the fragrance mixes in the European baseline patch test series, in the files FM I 
and FM II have been recorded 23 and 44 (PC) times, respectively, that is, when one of the 
ingredients of these mixes was indeed found to be present in the causal product. Their ingredients 
were suspected to be present 117 and 29 (PNC) times, respectively. However, the results obtained 
with FM I and FM II had not always been indicated in the files, even when an individual ingredient 
reacted positively; moreover, the ingredients of the mixes were not tested in all subjects. 
 The specific fragrance allergens correlated with 15 categories of cosmetic that produced a 
positive patch test reaction or usage test result, with a predominance of certain allergens in certain 
product categories (Table 1). Eaux de toilette/fine perfumes were the most frequent, with 62 PC and 
186 PNC fragrance allergens. They were followed by: skin care products, with 77 PC and 72 PNC 
allergens; deodorants, with 36 PC and 53 PNC allergens; hair care products, with 50 PC and four 
PNC allergens; bath and shower products, with 34 PC and seven PNC allergens; shaving products, 
with six PC and 20 PNC allergens; sun products, with seven PC and 15 PNC allergens; and toilet 
soaps, with seven PC and 11 PNC allergens. Less common products were: facial cleansers, with 
seven PC allergens and one PNC allergen; intimate hygiene products, with seven PC allergens; 
toothpaste, with four PC allergens and one PNC allergen; massage products, with one PC allergen 
and four PNC allergens; makeup, with one PC allergen and two PNC allergens; and depilating 
products and self-tanning products, each with one PC allergen (Table 1). 
 Geraniol in FM I and hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC) in FM II, as 
well as limonene, in particular, were the most frequent ingredients for which presence could be 
confirmed in the causal specific cosmetic products, and, together with hydroxycitronellal and 
Evernia prunastri in FM I, were the most frequent fragrance allergens also suspected to be present. 
 The results for the number of cosmetic products per year and the percentages of the most 
common fragrance allergens are shown in Fig. 2. In addition, Fig. 3 shows the trends in frequency 
over the years (2000–2009) of the most common fragrance allergens, expressed as percentages. 
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Fig. 2. Number of causal cosmetic products collected per year, along with the percentages of the 
most common fragrance allergens. FM I, fragrance mix I; FM II, fragrance mix II; HICC, 
hydroxyisohexyl 3-cyclohexene carboxaldehyde; Oak moss, Evernia prunastri. 
 
 
Fig. 3. Trends in frequency (%) over the years of the most common fragrance allergens included in 
the study. FM I, fragrance mix I; FM II, fragrance mix II; HICC, hydroxyisohexyl 3-cyclohexene 
carboxaldehyde; Oak moss, Evernia prunastri. 
 
Discussion 
 FM I, Myroxylon pereirae, colophonium (although to a minor extent) and the more recently 
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introduced FM II (Bruze et al, 2008) are the diagnostic markers for perfume allergy in the baseline 
patch test series (Uter et al, 2005; Marks et al, 1998; Nardelli et al, 2008; Thyssen et al, 2008). 
Cude M.pereirae, as such, has not been used in perfumery since 1982, when the International 
Fragrance Association banned its use in fragrances (IFRA, 2008), but there is still use of the extract 
or distillate of M. pereirae (Api, 2006). M. pereirae and colophonium do not need to be labelled; 
hence, reactions to them cannot be specifically correlated with specific cosmetic products. 
Concerning the trends in the fragrance sensitivity rate (Figs. 2 and 3), a fluctuating trend, either 
increasing or decreasing, was observed for the most common fragrance allergens. However, since 
2005, an increasing trend was observed for FM II, whereas in the case of FM I, a decreasing trend 
was observed. This fact can be explained by the change in the composition of the fine perfumes 
(Rastogi et al, 2003). This underlines the usefulness of FM II in diagnosing fragrance allergy 
(Frosch et al, 2005a; Heisterberg et al, 2010;Uter et al, 2010; Krautheim et al, 2010). In addition, 
the value of testing other allergens, such as FM II and limonene, is demonstrated: 40% of the 
reactions in 2009 were attributable to these. 
 In the current study, the fragrance allergens identified most often correlated with eau de 
toilette/fine perfumes, which contain higher concentrations of fragrance chemicals, as well as with 
skin care products (moisturizers) and deodorants. Indeed, leave-on products are more likely to cause 
allergic contact dermatitis than rinse-off products, such as those used for cleansing. 
 Among the most frequent individual allergens, we found geraniol, which has been rarely 
reported as a fragrance allergen, and particularly HICC, with the highest frequency from 2002 to 
2004; this, as described previously, is often responsible for axillary dermatitis, because of its use in 
deodorants (Nardelli et al, 2008; Rastogi et al, 1998). 
 Limonene was also a frequent allergen identified in several cosmetic products involved, also 
showing an increasing trend. According to the literature (Matura et al, 2003), limonene and linalool, 
the latter having caused only a few reactions in our study, are among the most commonly found 
fragrance ingredients in consumer products, not only in cosmetic but also in domestic and 
occupational products, in particular (Matura et al, 2003). For example, it was shown that 97% of the 
deodorants analysed contained linalool, whereas it was present in 61% of the so-called household 
products (soaps, surface cleaners, fabric conditioners, and laundry detergents for hand washing and 
dish washing) investigated; 78% of the latter contained limonene (Rastogi et al, 2001). 
Furthermore, linalool was found to be present in 91% of analysed cosmetic products on the Dutch 
market (de Groot et al, 1994). Both terpenes are also common constituents of several essential oils 
(including rose, lavender and geranium oils) and are not allergenic by themselves, but because of 
their oxidation products, mainly hydroperoxides (Sköld et al, 2002). Although patch test material of 
the oxidized forms of linalool and limonene is not yet commercially available, we did test with aged 
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materials, and thus obtained positive patch test results. As shown in Table 1, some essential oils 
were responsible for reactions to several specific cosmetic products, lavender oil being the most 
frequent. 
Restrictions on the use in cosmetic products of the specific fragrance allergens 
found 
 Restrictions on the use concentrations of certain allergens, such as isoeugenol, HICC, and E. 
prunastri, have been applied over the years. Besides EU regulations, the International Fragrance 
Research Association (IFRA, which provides recommendations to the perfume industry regarding 
the use of certain fragrance allergens, and which has guidelines on all of the 26 fragrance materials 
that need to be labelled), suggested in their guidelines that until May 1998, isoeugenol, for example, 
could safely be used at a level of 0.2% in consumer products (White et al, 1999), to be reduced in 
1998 to 0.02% (IFRA, 2008). IFRA has since further restricted its use, and has revised the guideline 
on this material numerous times, most recently in 2008, when the use of isoeugenol was limited to 
0.01% in category 1 (lip products) and category 2 (deodorants) (IFRA, 2008). 
 Chemical analysis of common cosmetic products, such as best-selling women’s perfumes, 
natural ingredient- based cosmetics, lower-priced cosmetic products, ordinary leave-on cosmetic 
products, and children’s cosmetics and cosmetic toys, has demonstrated the presence of isoeugenol 
in up to 70% of the investigated products, and at concentrations in the range 0.001 – 0.17%. 
Bruze et al. recommended that the concentration of isoeugenol should be lower than 0.0063% in 
deodorants, although studies to determine the most appropriate concentration remain to be 
performed (Bruze et al, 2005). 
 In the present study, isoeugenol was not a common allergen found in the causal cosmetic 
products, possibly as a result of such restrictions; however, isoeugenol may be substituted by 
isoeugenol esters, which are not labelled but end up in the skin as isoeugenol (Tanaka et al, 2004), 
for which new regulations would be appropriate. 
 HICC has been used in consumer products for many years, without limitations. In 2003, the 
EU scientific advisory committee recommended that its concentration be limited to 0.02% (200 
ppm) in cosmetic products (EU Commission, 2003). However, a more recent study showed that it 
was found in most perfumes and at maximum concentrations exceeding the recommendation for 
safe usage as issued by the advisory committee, by a factor of 10 (Rastogi et al, 2007). A recent 
IFRA standard (in August 2009) recommended that the HICC concentration should be decreased to 
0.02% in categories 1 (lip products and toys), 2 (deodorants and antiperspirants), and 7 (intimate 
and baby wipe products), and to 0.2% in products belonging to other cosmetic categories (IFRA, 
2009). According to our results, HICC is still a common allergen in several cosmetic categories. 
 With regard to E. prunastri, in 2004 the EU Scientific Committee on Consumer Products 
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(SCCP) had also recommended that atranol and chloroatranol, the main allergens in oak moss 
absolute, because of their strong sensitizing potential, could not be present in any cosmetic product, 
and considered untreated oak moss to be unsafe for the consumer (SCCP, 2004). The most recent 
revision by the IFRA was issued in 2008, limiting the use of E. prunastri to 0.02% for category 1 
and 0.03% for category 2, with atranol and chloroatranol below 100 ppm each (IFRA, 2008). In 
2008, on the basis of new experimental sensitization data on chemically treated and untreated oak 
moss absolute samples, the SCCP was of the opinion that treatment of oak moss absolute at a 
laboratory scale was able to reduce the levels of atranol and chloroatranol to less than 2 ppm each 
(SCCP, 2008). In our study, the presence of E. prunastri was confirmed in only two causal cosmetic 
products, although it was suspected to be present in 35 products (30 of them before 2005), eaux de 
toilette (n = 24 PNC) being the most frequent cosmetic category. Here again, the low number of 
reactions observed after 2005 probably reflects its restriction. 
Advice to fragrance-allergic patients 
Of the 30 fragrance allergens found in our study, 18 have been required to be labelled since March 
2005. However, managing patients with confirmed fragrance allergy often still proves difficult. 
Advising patients to use products without their specific fragrance allergen or to use those labelled as 
‘fragrance-free’ will not necessary lead to avoidance of all contact with fragrance materials, owing 
to the possibility of cross-reactions to components that are not labelled or to discrepancies in the 
accepted definition of the term. Fragrance is defined as any substance, natural or synthetic, used 
solely to impart an odour to a cosmetic product. However, if a fragrance material has more than one 
function (e.g. benzyl alcohol as a preservative or methyl benzoate as an emollient), it could legally 
still be included in a fragrance-free product (Scheinman, 1999). There are also masking fragrances 
that may also (although rarely) produce contact allergy. Moreover, consumers may be unaware that 
flower (plant) extracts and flavourings are, in fact, fragrance materials, their INCI names being in 
Latin on the cosmetic labels (Nardelli et al, 2009c). 
Limitations of the study 
The main limitation of our study is the collection of the data: the results obtained with FM I and FM 
II had not always been indicated in the files, even when an individual ingredient reacted positively; 
moreover, the ingredients were not tested in all subjects reacting to the mixes. Other limitations of 
the study are that it is retrospective and that the numbers are much smaller for 2000–2004. During 
the first period, many cases had indeed not been carefully documented, and there is also an apparent 
rise in cosmetic allergy cases in our unit. 
 
Conclusions 
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Labelling of the 26 individual fragrance ingredients, which has only been required since 
March 2005, has proven to be very useful in order to identify specific allergens in contact dermatitis 
patients suffering as a result of the use of fragrance-containing cosmetic products, to guide 
fragrance-allergic individuals who still wish to use fragrance-containing products in finding ‘safer’ 
alternatives – although this is not always easy and they are not always effective – and, as in this 
study, to determine the relevance of the fragrance allergens found in relation to the different 
categories of the causal cosmetic products. Studies of this type might also provide insights into 
current exposure to fragrances in cosmetic products and reflect the results of restrictions on specific 
ingredients. They could therefore also constitute a valuable basis for conducting further safety 
assessments. 
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SUMMARY 
Background: The frequency of fragrance contact allergy has shown a fluctuating trend over the 
years. 
Objectives: To describe the frequency of positive reactions to the baseline screening agents and 
fragrance mix (FM) 1 and 2 components, to determine trends of the latter over the years, and 
evaluate simultaneous reactions. 
Patients and methods: This was a cross-sectional study on patch-test results of 13 332 patients from 
January 1990 to December 2011. 
Results: Of the total population, 9.6% reacted positively to FM 1, and 6% of 3416 tested to FM 2 
reacted positively. Of those tested with both, 30,4% of 349 FM 1-positive patients reacted to FM 2, 
and 51,7% of 205 FM 2-positives patients reacted to FM 1. Hydroxyisohexyl 3-cyclohexene 
carboxaldehyde (HICC) and FM 2 were tested simultaneously in 3401 patients: 6 reacted to HICC 
alone. Nine hundred and forty patients were tested with FM 1 ingredients and 205 with FM 2 
ingredients; Evernia prunastri was the most frequent FM 1 allergen, and HICC was the most 
frequent FM 2 allergen. Simultaneous reactions were frequently observed. 
Conclusions: Fragrance-allergic subjects often show multiple positive reactions, some of which are 
highly significantly associated. Recently, there has been a decreasing trend in positivity for both 
Evernia prunastri and HICC, whereas a slight increase for cinnamyl alcohol has been observed. 
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Sensitivity to fragrance ingredients is recognized as a common and clinically important problem in 
Europe. It has been shown that 7-11.5 % of the individuals with eczematous skin conditions 
(Heisterberg et al, 2010-Thyssen et al, 2009), and at least 1-3 % of the general population, are 
allergic (delayed hypersensitivity) to baseline indicators of fragrance allergy (Uter et al, 2010). This 
makes contact sensitization to fragrances among the most common causes of allergic contact 
dermatitis, next to nickel and preservative agents. Although progress has been made in improving the 
safety standards of fragrances, the figures on adverse effects reported by dermatologists worldwide 
suggest that they are far from sufficient. 
The currently used fragrance mix (FM) 1 (containing Evernia prunastri, isoeugenol, 
cinnamal, cinnamyl alcohol, hydroxycitronellal, eugenol, geraniol and -amyl cinnamal) in the 
European baseline patch test series fails to detect a substantial number of clinically relevant 
fragrance allergies. It has been estimated that at least 15% of relevant cases of perfume allergy are 
not recognized by routine patch testing with FM 1 (Frosch et al, 2005a). However, Larsen et al. 
have reported that as much as 33% of fragrance sensitivity may be missed if it is used as the only 
test substance (Larsen et al, 1998), a percentage that might be even higher, as it depends on other 
fragrance components (and products) tested. For this reason, since 2005, a mixture of six additional 
fragrance materials has been commercialized for introduction into the baseline series (officially 
introduced in 2008) (Bruze et al, 2008), known as FM 2 [tested 14% in petrolatum, i.e. 
hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC), citral, farnesol, coumarin, citronellol, and 
-hexylcinnamal]. These are all fragrance components with known sensitisation properties and 
widely used in cosmetics, household and industrial products, but also in topical pharmaceutical 
products (Nardelli et al, 2009b). 
The pattern of fragrance contact allergy has changed over time because of industry 
developments, changing fashion trends, and regulatory interventions (Thyssen et al, 2008). The 
frequency of FM 1 contact allergy has shown a fluctuating trend over the years, either increasing or 
decreasing (Nardelli et al, 2008). In Denmark, an increase in frequency of FM 1 was observed from 
1985-1986 to 1997-1998 in both men and women, followed by a decrease in 2006 (Thyssen et al, 
2009). In a recent European multicentre study, FM 1 presented a wide frequency range depending 
on the countries studied; this ranged from 3.7% to 10.4%. The prevalence of sensitization to FM 1 
was lowest in the southern countries (Italy and Spain) and Lithuania, and highest in western and 
central Europe (Uter et al, 2012a).  
This study describes the frequency of positive reactions to FM 1 and 2, and to the individual 
components along with trends in their frequency over the years in our department. Furthermore, this 
study was also set up to evaluate associations between positively reacting FM I ingredients and 
Myroxylon pereirae (MP) and colophonium. 
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MATERIALS AND METHODS 
Study population 
This was a cross-sectional study for which all data were retrieved from, and evaluated with 
in-house developed databases in our Contact-allergy unit (Goossens et al, 1998). The patient 
database contains patients’ information and results of patch tests of 13.332 patients investigated for 
contact allergy between January 1990 and December 2011. 
Patch testing 
All subjects have been tested with the European baseline series (Trolab, Hermal, Reinbeck, 
Germany) containing fragrance mix 1 (FM 1), balsam of Peru (Myroxylon Pereirae), colophonium. 
Since 2002, 3927 were tested to HICC 5% pet. and from 2005 on 3416 to FM 2. The patients 
reacting to FM 1 and FM 2 were, in most cases, tested with the individual ingredients and some of 
the subjects were occasionally also tested with other fragrance components.  
The patch tests were administered with Van der Bend patch-test chambers (Van der Bend, 
Brielle, the Netherlands) applied on the back with Micropore™ (3M Health Care, Borken, Germany), 
and fixed with Fixomull® (Beiersdorf, Germany), and later on with Mefix® (Mölnlycke Health Care, 
Göteborg, Sweden). The patch-test readings were performed according to the international guidelines 
by the International Contact Dermatitis Research Group (ICDRG) (Wenninger et al, 2000) after 2 
days, 3 days (exceptionally), and 4 days, and sometimes later. 
 
Statistical analysis 
 The fragrance ingredients present in FM 1 and 2 were studied in an explorative way. The 
study of simultaneous positive reactions to FM 1 ingredients, as well as to MP and colophonium are 
presented in a 2x2 contingency table. As an appropriate statistical measure to compute the strength 
and the direction of the association, we used the odds ratio (OR), expressing the occurrence of 
positive reaction in one group as compared with another group, and their corresponding 95% 
confidence interval (CI). If the CI is different from 1, there is a significant association between the 
row and the column variable. This is an explorative study, therefore we are not correcting for 
multiple tests. The statistical analysis in the patch-tested patients was performed by using the SAS 
SOFTWARE SYSTEM version 9.2 (SAS Institute Inc., Cary, NC, USA). 
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RESULTS 
 Of the 13.332 patients who underwent patch testing between January 1990 and December 
2011, 7486 or 56% patients presented with at least one positive patch test reaction. 1259 (9.6% out of 
13114 patients tested) of them reacted positively to FM 1 and 205 (6% out of 3416 patients tested) to 
FM 2. 3380 patients were tested to both FM1 and 2: 106 (30,4%) out of the 349 positive patients to 
FM 1 also reacted to FM 2, while 106 (51,7%) out of 205 FM 2 positives also to FM1. 82 patients 
(2.09% out of 3927 tested) presented with a positive reaction to HICC (Table 1). 18 HICC-allergic 
patients did not react to FM 1. During the period 2005-2011, HICC and FM2 were tested 
simultaneously in 3401 patients: only 6 were positive to HICC alone. 
 
Table 1. Positive reactions observed to fragrance mix (FM) 1, hydroxyiso-hexyl 3-cyclohexene 
carboxaldehyde (HICC) and FM 2 
 
 Patients tested with 
FM 1 (n=13114)* 
Patients tested with 
HICC (n=3927)+ 
Patients tested with 
FM 2 (n=3416)# 
Positive reactions 1259 82 205 
Percentage (%) 9.6 2.09 6 
*Between 1990-2011. 
+ Between 2002-2011. 
# Between 2005-2011. 
 
 
Most patients underwent a full breakdown test when a positive reaction to FM1 or either FM 
2 occurred. 940 patients were tested with the FM 1 ingredients: the frequency of positive reactions 
in descending order was: 24.6% (n= 230) to Evernia prunastri, 17% (n=160) to isoeugenol, 13.7% 
(n=129) to cinnamic alcohol, 12.5% (n=118) to eugenol, 7% (n=66) cinnamal, 5.5% (n=52) 
geraniol, 3.2% (n=30) -amyl cinnamal and 2.6% (n=24) to hydroxycitronellal (Table 2). With the 
breakdown constituents of FM 2 tested in 205 subjects, HICC was by far the most common 
sensitizer (n=58), followed by farnesol (n=27), citral (n=23), hexylcinnamal (n=20), citronellal 
(n=11), and coumarin (n=9) (Table 3). 
 
Table 2. Positive reactions to the constituents of fragrance mix (FM) 1 between 1990-2011 
 
Constituents Total (n=940)* Percentage 
Evernia prunastri 230 24.6 
Isoeugenol 160 17 
Cinnamic alcohol 129 13.73 
Eugenol 118 12.6 
Cinnamal 66 7 
Geraniol 52 5.5 
 amylcinnamic aldehyde 30 3.2 
Hydroxycitronellal 24 2.6 
*Nine hundred and forty patients were tested with the FM 1 ingredients. 
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Table 3. Positive reactions to the constituents of FM 2 between 2005-2011 
 
Constituents Total (n=205)* Percentage 
HICC 58 28.3 
Farnesol 27 13.2 
Citral 23 11.2 
Hexyl cinnamal 20 9.7 
Citronellol 11 5.4 
Coumarin 9 4.4 
HICC, hydroxyisohexyl 3-cyclohexene carboxaldehyde. 
*Two hundred and five patients were tested with the FM 2 ingredients. 
 
The results of absolute numbers in frequency of the different ingredients of FM 1 (1990-2011) and 
FM 2 (2005-2011) obtained over the years are given in Figures 1 and 2, respectively. 
 
 
 
Figure 1. Evolution of the absolute numbers in frequency over the years of positive reactions to the 
different ingredients of fragrance mix 1 (1990-2011).  
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Figure 2. Evolution of the absolute numbers in frequency over the years of positive reactions to the 
different ingredients of fragrance mix 2 (2005-2011). HICC, hydroxyisohexyl 3-cyclohexene 
carboxaldehyde. 
 
The associated positive tests observed with the different ingredients of FM1, MP and 
colophonium are given in Table 4 showing an association for all comparisons reported. When 
significant, the OR was computed. As an example, an OR of 915.09 (Table 4) means that the odds 
of a positive reaction to cinnamic alcohol is 915.0 times higher for patients with a positive reaction 
to cinnamal than for the non-cinnamal allergic patients. 
 
Table 4. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) for the different 
fragrance mix 1 ingredients and Myroxylon pereirae and Colophonium 
 
Allergens OR (95% CI) 
Cinnamic alcohol by Cinnamal 915.0 (428-1955) 
Isoeugenol by Eugenol 140.6 (92-215) 
Cinnamic alcohol by Amylcinnamaldehyde 98.7 (45-217) 
Amylcinnamaldehyde by Hydroxycitronellal 56.4 (23-138) 
Cinnamal by Amylcinnamaldehyde 55.1 (20-152) 
Geraniol by Hydroxycitronellal 50.9 (24.18-107.5) 
MP by Eugenol 46.9 (31-72) 
Isoeugenol by Oakmoss 42.9 (30-62) 
Eugenol by Cinnamic alcohol 38.3 (23-63) 
Isoeugenol by Geraniol 33.3 (17-66) 
Hydroxycitronellal by Oakmoss 32.5 (15-68) 
Eugenol by Oakmoss 29.7 (19-46) 
Isoeugenol by Hydroxycitronellal 28.7 (17-50) 
Amylcinnamaldehyde by Oakmoss 28.5 (13-64) 
Eugenol by Cinnamal 26.4 (13-54) 
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MP by Isoeugenol 25.4 (18-36) 
Geraniol by Oakmoss 25.2 (16-39) 
Cinnamic alcohol by Oakmoss 25.1 (16-39) 
Cinnamal by Hydroxycitronellal 24.5 (11-56) 
Cinnamic alcohol by Hydroxycitronellal 22 (12-42) 
Geraniol by Eugenol 21.4 (9-49) 
Geraniol by Cinnamal 17.4 (5-58) 
Eugenol by Hydroxycitronellal 16.4 (8.21-33) 
Isoeugenol by Cinnamic alcohol 14.4 (8-26) 
Isoeugenol by Amylcinnamaldehyde 14.1 (5-41) 
MP by Geraniol 13.6 (7-25) 
MP by Cinnamic alcohol 13 (9-19) 
MP by Cinnamal 12 (7-21) 
Colophonium by Amylcinnamaldehyde 11.8 (5-26) 
Cinnamal by Oakmoss 11.6 (6-24) 
Isoeugenol by Cinnamal 10.5 (4-25) 
MP by Oakmoss 9.3 (7-13) 
Eugenol by Amylcinnamaldehyde 8.4 (2-36) 
MP by Amylcinnamaldehyde 7.7 (3-17.22) 
Colophony by Geraniol 6.9 (3-14) 
MP by Hydroxycitronellal 6.4 (4-11) 
Colophonium by Cinnamic alcohol 6 (4-10) 
Colophonium by Eugenol 5.9 (4-9) 
Colophonium by Oakmoss 5.8 (4-8) 
Colophonium by Isoeugenol 4.4 (3-7) 
Colophonium by Hydroxycitronellal 3.9 (2-7) 
Colophonium by Cinnamal 3.5 (2-8) 
 
 
DISCUSSION 
 We observed a frequency of 9.6 % positive reactions to FM 1, with its ingredients showing a 
fluctuating trend. Evernia prunastri was the most frequent allergen among them, with a remarkable 
peak in 1997 and 2000, the pattern of which could be attributed to the fashionable use of it in some 
cosmetics products, especially aftershaves and hydroalcoholics. Among the >100 constituents 
identified in Evernia prunastri, atranol and chloroatranol (degradation products of atronorin and 
chloroatranorin) figure as the most potent allergens (Johansen et al, 2006); in view of their extreme 
sensitization potencies, the Scientific Committee of Cosmetics (SCCP) came to the conclusion that 
both substances could not be used at all in cosmetics products (SCCP/0847/04) (Nardelli et al, 
2009a). In addition, significant associations have earlier been observed for colophonium and 
Evernia prunastri (with Evernia furfuracea as a contaminant or substitute) because of the potential 
common presence of resin acids i.e. abietic acid and dehydroabietic acid, and their oxidized 
derivatives (Johansen et al, 2006). Moreover, a recent study by Uter et al. has identified two 
subgroups of Evernia furfuracea-sensitized patients, first those with sensitization to (oxidized) resin 
acids, as indicated by positive patch test reactions also to colophonium, and second those non-
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sensitized to resin acids, but sensitized to common constituents of Evernia prunastri and Evernia 
furfuracea (Uter et al, 2012b). Furthermore, colophonium, MP and FM 1 also cross-react with other 
terpene-containing substances, among which essential oils but also compositae plants (Paulsen et al, 
2005) (data on file).  
 The crude MP as such has not been used in perfumery since 1982, when de International 
Fragrance Association (IFRA) banned its use in fragrances. Since 1995 (Api et al, 2006), MP has 
been incorporated in fragrances as an extract or distillate, but patch testing showed that MP-
sensitized subjects even react more strongly to these extracts. Exposure to MP, or to some of the 
single constituents, is apparently frequent, hence this ‘historical’ screening agent still remains 
important to detect fragrance sensitivity (Nardelli et al, 2008). 
 In the current study, FM 2 identified 6% of the subjects suffering from fragrance allergy, with 
99 fragrance-allergic patients missed if only FM 1 had been tested. There was also a fluctuating 
trend in frequency to FM 2’s ingredients, in which HICC was the most frequent allergen with an 
ascendance peak in 2007 but a descending one since 2009. In the case of hexyl cinnamal a moderate 
increase was observed in the last year. The high frequency could then be attributed to the common 
use of HICC in deodorant and other cosmetics product in EU, in rather high use concentrations, i.e. 
more than 3.0% in certain perfumes, which resulted in positive reactions in 1-2.7 of consecutively 
patch tested patients (Johansen et al, 1995-Larsen, 2002- Frosch et al, 1995- Frosch et al, 1999-
Frosch et al, 2002). In North America, the prevalence was then found to be only 0.4%, which was 
considered to be mainly because of the presence of the ingredient in much lower concentrations in 
deodorants in the USA compared to the EU (Bruze et al, 2008). Recently, also Schnuch et al. 
(Schnuch et al, 2012) did observe a slight decrease of positive reactions to HICC, which may be the 
result of diminished exposure (used in less products and in lower concentration, the latter having 
been recommended by the International Fragrance Association (www.ifraorg.org) who, since 2009 
provided guidance in this regard: 0.02 % for deodorants, lip products, and intimate wipes, and 0.2% 
for all other leave-on and rinse-off cosmetics (Api et al, 2010). However, in agreement with our 
results, in a recent study in which the 26 labelled fragrance ingredients were investigated, HICC 
still remained among the most frequent allergens (Heisterberg et al, 2011). 
 Significant associations between cinnamal and cinnamic alcohol, as well as with MP in which 
both are present, were observed (Table 4). The IFRA restricts the use concentration in cosmetic 
products of cinnamic alcohol to 0.1% for deodorant and lip products, whereas cinnamal has specific 
concentration restrictions to 0.02% for deodorant, lip products and 0.05% for the other cosmetic 
categories (43rd Amendment, IFRA standard 2009). It has been reported that cinnamal and cinnamic 
alcohol may generate a common hapten. This may be due either to their close chemical relationship, 
causing cross sensitization, or to their combined presence in many cosmetic products, leading to 
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concomitant sensitization. It is thought that cinnamic alcohol is a ‘prohapten’, transformed by 
alcohol dehydrogenase (ADH) in the skin to cinnamal. However, we found cinnamic alcohol to be a 
more important allergen than cinnamal, which could be explained by an additional sensitization 
mechanism (Buckley et al, 2006- Lepoittevin JP, personal communication 2012). Moreover, in 
agreement with the literature (Foti et al, 2011a-Devleeschouwer et al, 2008), cinnamyl alcohol 
contact allergy is very often related to ketoprofen photosensitization (which explains its recent 
slight increase in frequency): during the study period 48 out of 81 ketoprofen-positive patients were 
also tested to cinnamyl alcohol of whom 37 reacted positively, while only 6 out of 45 tested to 
cinnamal reacted to it; this even renders cinnamyl alcohol a potential marker for ketoprofen 
sensitization. Some authors (Girardin et al, 2006-Foti et al, 2011b-Stingeni et al, 2010) considered a 
possible cross-sensitization between ‘an aldehyde function’ in the ketoprofen molecule and 
cinnamic aldehyde, or formation of common metabolites (Girardin et al, 2006). However, a clear 
explanation for this phenomenon is still lacking. 
 Significant associations were also found between isoeugenol and eugenol, the former 
recognized as a strong sensitizer with its concentration in cosmetics being restricted by IFRA since 
1998; in 2009 the IFRA standard (43rd Amendment) changed the restriction on isoeugenol to 0.01% 
for deodorants, lip products and 0.02% for hydroalcoholics, aftershaves, women facial and hand 
creams, intimate wipes and make up removers. On the other hand, eugenol is a much weaker 
sensitizer (Buckley et al, 2006). They do not in fact cross-react, despite their close chemical 
similarity and are both prohaptens that metabolise in the skin. According to our results the OR of 
simultaneous association was still important (140.6), but considerably lower than with the cinnamic 
derivates. Moreover, simultaneous reactions were found with MP that contains, beside other 
components, both eugenol and isoeugenol.  
 With regard to other significant associations (Table 4), no molecular explanation can be put 
forward, but concomitant sensitization seems likely; indeed, fragrance-allergic subjects tend to 
present multiple sensitivities. 
 A significant number of subjects (n=131) reacted negatively to the breakdown constituents but 
positively to FM 1, a phenomenon also noted by others (Uter et al, 2010-Johansen et al, 1995-
Buckley et al, 2006). Possible explanations are: 
-  false-positive reaction to the mix 
- each constituent acts as an irritant, which lowers the elicitation threshold for other allergens 
when tested in combination 
- false-negative reactions to the individual constituents of the fragrance mix, because the 
concentrations tested are too low, or the skin penetration  of FM 1 is increased by the 
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emulsifier sorbitan sesquioleate (also present though in Evernia prunastri) (Buckley et al, 
2006)  
- the existence of “compound allergy” to a combination of two or more ingredients of FM 1, i.e. 
by the formation of a new allergen (Johansen et al, 1995) 
- a different evaporation potential of individual components compared to the mixture. The 
conditions under which the fragrance test preparations are stored when applied in test 
chambers may affect the diagnostics of fragrance contact allergy, resulting in false-negative 
reactions. As many fragrance compounds are volatile, application to the test chamber should 
be performed as close in time to the patch testing as possible and storage in a refrigerator is 
recommended (Mowitz et al, 2012) 
- Cinnamal and cinnamyl alcohol were found (Mowitz et al, 2012) to be more stable when 
analysed as ingredients in FM 1 compared with when analysed in individual preparations. 
 
 A recent study by Bonefeld et al (Bonefeld et al, 2011) has indeed shown that mixtures have 
an increased potency in sensitization and elicitation of contact allergic reactions as compared with 
isolated fragrance allergens. These results may explain why fragrance allergy is a prevalent 
phenomenon in spite of the fact that many fragrance allergens are categorized as weak sensitizers. 
The authors consider that mixtures of fragrances, i.e. FM1 and FM 2, not only reflect normal 
exposures to perfumes, but also provide the optimal stimulus to the immune system, thereby 
expressing high diagnostic ability. Hence, in the light of the Bonefeld study, false-negative 
reactions to the ingredients certainly also account for this phenomenon (Bonefeld et al, 2011). 
 
Limitations of the study 
The main limitation of our study is that the individual ingredients of FM 1 and/or FM 2 were 
not tested in all subjects reacting to the mixes. This is because testing was only performed with the 
individual ingredients when the FM-sensitive patients were able to come back for later readings. 
Secondly, this was a single-centre study. Therefore, only a relatively low number of patients were 
positive to the individual ingredients of the mixture. However, we consider that the present study on 
fragrance materials expands on previous work from our unit (Nardelli et al, 2008); and provides a 
current perspective on the frequency of sensitization to FM 1 and 2 in the European baseline series 
and their ingredients, as well as simultaneous reactions observed to MP and colophonium.  
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CONCLUSIONS  
Evernia prunastri and isoeugenol were found to be the most common single fragrance 
allergens in FM 1, whereas HICC and to a far less extend farnesol in FM 2.  
Positive reactions to MP and FM 1 are frequently associated because they share common 
components, i.e eugenol, iso-eugenol, cinnamal, and cinnamic alcohol. The association between 
colophonium and FM 1 is partly due to the presence of resin acids in Evernia prunastri, but together 
with MP also to (oxidized) terpenes, being present in essential oils and Compositae plants as well. 
 A fluctuating trend in frequency of positive reactions has been observed with the individual 
ingredients of the mixes, with a recent slight increase for cinnamyl alcohol, being associated with 
ketoprofen photosensitization, and a descending trend, particularly for Evernia prunastri and HICC. 
This could be explained by concentration restrictions (e.g. HICC), fashionable fragrance composition 
changes, and last but not least by avoiding the use of the components legally required to be labelled 
on the cosmetic packaging by the perfume industry. 
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Chapter 10 
 
Discussion and Future Perspectives 
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The first objective of this thesis was to determine the frequency of contact allergy to 
fragrance allergens. Our study, in which 6 to 9% of the patients investigated for contact allergy 
during a 15-year period reacted to the fragrance markers in the baseline series, is in agreement with 
the literature, according to which its frequency is between 6-14% in patients with contact eczema 
(de Groot, 2001-Buckley et al, 2003-Mortz et al, 2013). In the past decade, the prevalence of 
fragrance sensitivity, evaluated by testing only with FM I, varied considerably though. A percentage 
between 7 and 10 was observed among patch-tested patients in Europe (Schnuch et al, 2004- 1997-
Temesvari et al, 2002-Bangha et al, 1996-Hasan et al, 2005- Buckley et al, 2000).  
 We observed a fluctuating, slightly decreasing trend in frequency of positive reactions and 
some of their ingredients over the years (Chapters 5 and 9). In Denmark, FM I reactions rose from 
4.1% in 1985–1986 to 9.9% in 1997–1998 (Johansen et al, 2000), and a similar rising tendency was 
reported in Slovenia as well (Lunder et al, 2000). However, a decrease in FM I sensitivity was 
reported in several other studies (Schnuch et al, 2004- Larsen et al, 1998- Wohrl et al, 2001- 
Schnuch et al, 1997- Temesvari et al, 2002); for example, according to a European multi-centre 
survey, the fragrance sensitivity rate had decreased significantly from 13.1% in 1999 to 7.8% in 
2002 (Bruynzeel et al, 2005). This was also observed in the USA, where the fragrance sensitivity 
rate diminished from 14% to 11.4% in the late 1990s (Marks et al, 1998-Marks et al, 2000) and, 
according to a more recent study, even down to 5.9% (Belsito et al, 2006). In the future, perhaps a 
further decrease in positive reactions to FM I allergens may be expected. Indeed, because of the 
labelling of 26 fragrance components by EU legislation (EU Directive, 2003), including those of 
FM I, as well as the outcome of recent dermatological studies on fragrance allergy and subsequent 
legal requirements [for example, reducing the concentration of isoeugenol (Tanaka et al, 2004)], the 
policy of some fragrance companies has changed. For instance, it has been shown that the new 
prestige perfumes contain less often or smaller amounts of fragrance chemicals included in FM I, 
compared with the older perfumes (Rastogi et al, 2003). Moreover, deodorants and domestic and 
occupational products quite often contain fragrance chemicals different from those present in FM I, 
such as limonene (Rastogi et al, 1998- Rastogi et al, 2001). This underlines the usefulness of new 
screening substances for the purpose of increasing the ability to diagnose fragrance allergy (Frosch 
et al, 2005 a-b). In 2005, Hasan et al. have shown that in contrast to FM I, there is a significant 
increase in the sensitivity rate to MP in recent years (Hasan et al, 2005), whereas the sensitivity rate 
to MP has been rather stable over the years in our study. Our studies, in agreement with others 
(Scheinman, 1996-Malanin et al, 1989-Malten et al, 1984) show that the majority of patients with 
fragrance sensitivity are women (Chapter 5), which reflects a greater exposure to fragranced 
cosmetics in them. Moreover, women with skin problems due to cosmetics might be more apt to 
consult a dermatologist. However, in view of an increasing usage also in men, the sex difference 
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may become less prominent in the future. 
 The frequency of fragrance allergy gradually increased from young to adult age, the highest 
peak being between 20 and 40 years (40%) for females and between 40 and 60 years (37.6%) for 
males, to decrease gradually again later on. The peak at that age in the female population could be 
explained by the greater personal use of fragranced products in young women, in particular. In 
males this could perhaps be explained by a different patient selection or a different consumer 
exposure. However, contact allergy to fragrance containing cosmetic products may also occur at an 
early age, as illustrated by our case report (see appendix): a severe allergic contact dermatitis 
occurred in the diaper area of an atopic one-year old baby-girl, due to contact allergy to both 
isoeugenol and parabens (the latter being weak allergens). The allergens were present in wipes and 
skin-care products especially designed for babies. Occlusion and barrier damage of the skin had 
facilitated skin sensitization. Hence, any child with persistent eczema, whatever the age, should be 
referred for patch testing. 
 The hands and face were the most commonly affected body sites, and significant associations 
between the type of fragrance and localizations were found (Chapter 5). Some fragrance allergens 
were specifically related to certain lesion localizations, for example, a significant association was 
found between HICC and axillae in females. The high frequency could then be attributed to the 
common use of HICC in deodorant and other cosmetics product in the EU, in rather high use 
concentrations, i.e. more than 3.0% in certain perfumes, which resulted in positive reactions in 1-
2.7% of consecutively patch tested patients (Johansen et al, 1995-Larsen, 2002- Frosch et al, 1999- 
Frosch et al, 1999-Frosch et al, 2002). In North America, the prevalence was then found to be only 
0.4%, which was considered to be mainly due to the presence of the ingredient in much lower 
concentrations in deodorants in the USA compared to the EU (Bruze et al, 2008). Recently, also 
Schnuch et al. (Schnuch et al, 2012) did observe a slight decrease of positive reactions to HICC, 
which may be the result of diminished exposure [used in less products and in lower concentration, 
the latter having been recommended by the International Fragrance Association (www.ifraorg.org) 
who, since 2009 provided guidance in this regard: 0.02 % for deodorants, lip products, and intimate 
wipes, and 0.2% for all other leave-on and rinse-off cosmetics (Api et al, 2010)]. However, in 
agreement with our results, in a recent study in which the 26 labelled fragrance ingredients were 
investigated, HICC still remained among the most frequent allergens (Heisterberg et al, 2011). 
We also determined the frequency of positive reactions to the FM I and FM II individual 
components (Chapters 5 and 9). Evernia prunastri was the most frequent FM I allergen, as was 
illustrated in Chapter 9, with, according to the literature chloroatranol and atranol as the main 
allergens (Bernard et al, 2003). As part of our studies on FM I ingredients, we could show that 
polymer-based treatment of oak moss extract reduces the allergenic elicitation potential in 
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previously sensitized individuals only to a minor extent (Chapter 6). However, in view of more 
recent data and considering elicitation, the major sensitizers atranol and chloroatranol should be 
eliminated completely from Evernia prunastri (oak moss absolute) in order to be safe for 
consumers. A recent study by Mowitz et al, showed that the thin-layer chromatography patch test 
indicates the presence of several other sensitizers other than atranol and choroatranol in oak moss 
absolute (Mowitz et al, 2013). 
 The second most important allergen in FM I was isoeugenol, whereas HICC and to a far less 
extend farnesol in FM II. The use concentration of certain allergen, such as isoeugenol, has been 
restricted over the years. Besides EU regulations, the International Fragrance Research Association 
(IFRA, which provides recommendations to the perfume industry regarding the use of certain 
fragrance allergens, and which has guidelines on all of the 26 fragrance materials that need to be 
labelled), suggested in their guidelines that until May 1998, isoeugenol, for example, could safely 
be used at a level of 0.2% in consumer products (White et al, 1999), to be reduced in 1998 to 0.02% 
(IFRA, 2008). IFRA has since further restricted its use, and has revised the guideline on this 
material numerous times, most recently in 2008, when the use of isoeugenol was limited to 0.01% 
in category 1 (lip products) and category 2 (deodorants) (IFRA, 2008). 
Positive reactions to MP and FM I were frequently associated because of common 
ingredients, i.e. eugenol, iso-eugenol, cinnamal, and cinnamyl alcohol. The association between 
colophonium and FM I, as has been said, is partly due to the presence of resin acids in Evernia 
prunastri, but together with MP also to (oxidized) terpenes, being present in essential oils and 
Compositae plants as well (Paulsen et al, 2005). 
For some of the ingredients of the fragrance mixes, there was a slight increase in frequency 
of positive reactions over the years, for example, to cinnamyl alcohol, which could be linked to its 
relationship with ketoprofen photosensitization (Devleeschouwer et al, 2008). For others, such as 
Evernia prunastri, HICC, and iso-eugenol, a recent slightly descending trend was observed. This 
could be partially explained by concentration restrictions (e.g. as for HICC and iso-eugenol); 
fashion-related fragrance composition changes; and lastly by introducing required labelling of the 
components on the cosmetic package, that perhaps also encourages the fragrance industry to omit 
the ingredients to be labelled. 
 Another objective of this thesis was to identify the nature of fragrance allergens in specific 
cosmetic products. Labeling of the 26 individual fragrance ingredients has indeed proven to be very 
useful in order to identify specific allergens in contact dermatitis patients with cosmetic intolerance. 
Of the 30 causal fragrance allergens identified in this study (Chapter 8), 18 had been required to be 
labelled since March 2005. In the 15 different categories of cosmetic products that were analysed, 
geraniol and hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC), as well as limonene, in 
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particular, were the most frequent ingredients for which their presence could be confirmed in the 
causal specific cosmetic products; moreover, hydroxycitronellal and Evernia prunastri were the 
most frequent fragrance allergens suspected to be present in such products. The value of testing 
other allergens, such as FM II ingredients and limonene has been demonstrated as well: 40% of the 
reactions in 2009 were attributable to them. In addition, some essential oils were responsible for 
reactions to several specific cosmetic products, lavender oil being the most frequent. The fragrance 
allergens identified in this study most often correlated with eau de toilette/fine perfumes and 
deodorants, which contain higher concentrations of fragrance chemicals and in the latter case in an 
occluded area; but also skin-care products (moisturizers) were involved. Indeed, leave-on products 
are more likely to cause allergic contact dermatitis than rinse-off products, such as those used for 
cleansing. 
However, managing patients with confirmed fragrance allergy often still proves difficult. 
Advising patients to use products without their specific fragrance allergen or to use those labelled as 
‘fragrance-free’ will not necessary lead to avoidance of all contact with fragrance materials, owing 
to the possibility of cross-reactions to components that are not labelled or to discrepancies in the 
accepted definition of the term. Moreover, labelling may be misleading. This was illustrated by a 
case report (shown at the appendix of this manuscript): a widespread allergic contact dermatitis 
resulted from skin application of a supposedly non-scented moisturizing body lotion in a patient 
known to be fragrance allergic. However, this lotion contained an extract of ‘Rosa centifolia’ (rose 
oil) that produced a positive patch test reaction, beside rose oil itself, farnesol, limonene and 
linalool; the latter two are indeed common ingredients of several essential oils (e.g. rose, lavender 
and geranium oils). Essential oils may, even at low concentrations, still elicit allergic reactions, 
especially in previously sensitized subjects as in this case. Therefore, statements such as ‘non-
scented’ or ‘fragrance- free’ should not legally appear on the label of products that contain essential 
oils or other fragrance ingredients, albeit for other purposes. Furthermore, this case also underlines 
that, when diagnosing contact allergy in fragrance allergic-patients, it is important to test with the 
compounds that the individuals actually come into contact with. 
Additionally, we determined which and how many topical pharmaceutical products in 
Belgium contained fragrances and examined the nature of the fragrance in products that played a 
role in iatrogenic ACD. In this regard, it is important to note that in Europe there is no legislation 
requiring labelling of individual fragrances in topical pharmaceutical products that are intended to 
be applied on diseased skin (Chapter 7). Indeed, 66 different fragrance components were identified 
in them and 10% of topical pharmaceutical products in Belgium were found to contain fragrance 
ingredients. Essential oils were present in several pharmaceutical topical products, particularly in 
those that were brought on the market  several decades ago. Unfortunately, they were also found in 
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more recently marketed preparations, particularly those containing non-steroidal anti-inflammatory 
drugs that are widely used. 
 The fragrance-allergy markers in the baseline series did pick up most of the patients sensitized 
to fragrance allergens present in the 48 specific causal topical pharmaceutical products, and in those 
38 different fragrance substances gave relevant positive reactions. This study also showed that 
beside the baseline series extended patch testing with the products used by the patient, along with 
the ingredients, is also needed because one fifth of them only reacted positively to an essential oil or 
to another fragrance allergen present. The possibility of testing all the components of a commercial 
product depends, of course, on the manufacturer’s goodwill to provide all ingredients. 
 Besides their use as a pharmacologically active ingredient in some cases, the use of fragrances 
in topical pharmaceutical products is unnecessary. Indeed, since such products are applied on more 
vulnerable, and often diseased skin (wounds, leg ulcers, eczema, etc.), they thus constitute another 
important source of fragrance sensitization, which predisposes the patients to develop multiple 
sensitivities and to react also to fragrance-containing cosmetics (and other fragranced materials). 
  
Conclusions  
Fragrance contact allergy is more frequent in females than in males and, over the years, 
fluctuating trends (either increasing or decreasing) in frequency of patch-test results with the 
fragrance allergy-markers and some of their ingredients have been observed. The frequency of 
fragrance allergy gradually increased from young to adult age, to decrease gradually again later on, 
however, contact allergy to fragrance containing cosmetic products may also occur at an early age. 
Hands and face were the most commonly affected body sites, followed by legs, arms, and axillae; 
moreover, some fragrance allergens were specifically related to certain lesion localizations, for 
example, a significant association was found between HICC and axillae, particularly in females. 
Positive reactions to the different markers were frequently associated, because of common 
ingredients, for example with MP and FM I, or due to the presence of the same or cross-reacting 
oxidized terpenic compounds, as with colophonium, FM I, essential oils, and Compositae plants. 
With regard to cosmetic products, geraniol and hydroxyisohexyl 3-cyclohexene carboxaldehyde 
(HICC), as well as limonene, in particular, were the most frequent ingredients for which their 
presence could be confirmed in the causal specific cosmetic products. As to topical pharmaceutical 
products in Belgium, 10% of them were found to contain 66 different fragrance components, among 
which several essential oils. Finally, our studies also showed that it is important to test not only with 
the fragrance allergy markers in the baseline series, or the ingredients of the fragrance mixes, but 
also with the products that the individuals actually come in contact with. 
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Future Perspectives 
- There	 is	no	doubt	 that	progress	has	been	made	 in	 improving	 the	safety	 standards	of	
fragrances,	 however,	 the	 figures	 on	 adverse	 effects	 reported	 by	 dermatologists	
worldwide	 suggest	 that	 these	 are	 not	 sufficient.	 Materials	 with	 a	 low	 potential	 for	
adverse	 effects	 may	 escape	 the	 laboratory	 screening	 methods	 available	 today.	
Therefore,	 a	 need	 has	 arisen	 for	 “in	 silico”	 methods	 (QSRA	 studies)	 and	 in	 vitro	
methods	 involving	human	or	animal	 cells	 to	 identify	potentially	hazardous	allergens,	
but	which	should	be	correlated	to	human	endpoints.	This	is	particularly	relevant	in	the	
context	 of	 prohibition	 of	 animal	 studies	 for	 cosmetic	 ingredients.	 However,	 in	 vitro	
tests	 for	 diagnostic	 purposes	 will	 not	 be	 widely/routinely	 available	 within	 the	
foreseeable	future.	This	means	that	diagnostic	patch‐testing,	a	bioassay	with	inherent	
pitfalls,	remains	the	“gold	standard”	and	the	only	tool	to	diagnose	contact	allergy	and	
evaluate	patients	with	suspected	allergic	contact	dermatitis.		
- In	 order	 to	 improve	 primary	 prevention	 of	 fragrance	 contact	 allergy	 in	 the	 general	
population,	and	secondary	prevention	 in	those	subjects	already	sensitized,	many	more	
fragrance	 allergens	 than	 those	 actually	 tested	 by	 clinicians	 should	 be	 investigated.	
Indeed,	besides	the	hydroperoxides	of	limonene	and	linalool	that	have	already	shown	to	
be	important	contact	allergens	in	the	clinic	(Bråred	Christensson	et	al,	2012,	2013)	and	
that	 are	 now	 commercially	 available	 as	 patch	 test	 materials,	 other	 fragrance	
components,	 which	 are	 classified	 in	 the	 report	 of	 the	 SCCP	 as	 established	 contact	
allergens	in	humans,	or	fragrance	sensitizers	identified	in	LLNA	essays	or	emerging	from	
QSAR	studies	should	be	made	available	for	patch	testing.	This	would	allow	to	evaluate	
their	 sensitizing	 potential	 in	 clinical	 settings,	 to	 monitor	 them	 and	 accordingly,	 to	
propose	 safety	 or,	 if	 necessary,	 legal	 measures	 (e.g.	 labelling,	 reducing	 use	
concentrations,	or	even	eliminating	certain	components).	
- From	 a	 clinical	 perspective	 it	 is	 important	 for	 the	 individual	who	 is	 sensitized	 to	 one	
fragrance	substance	to	know	if	they	must	also	avoid	chemically‐related	substances	that	
cross‐react	 with	 the	 original	 sensitizer.	 Cross‐reactions	 between	 chemically‐related	
substances	have	not	been	well	studied	so	far.	
- Dose‐response	data	from	clinical	studies	are	available	for	only	a	few	allergens.	In	order	
to	establish	individual	safe	levels,	such	data	are	required	for	all	established	allergens	of	
concern.	
- Most	 experimental	 studies	 are	 performed	 on	 individual	 fragrance	 ingredients,	 while	
exposure	to	allergens	in	cosmetic	products	concerns	allergen	mixtures,	 influencing	the	
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risk	 of	 sensitization	 and	 elicitation.	 Better	 knowledge	 about	 “cocktail”	 effects	 would	
improve	the	basis	of	risk	assessment	and	management.	
- Finally,	 the	 impact	 of	 the	 behavior	 of	 fragrance	 substances,	 such	 as	 volatility,	 and	
autoxidation	 processes	 and	 skin	 penetration,	 and	 metabolism	 (bio‐activation)‐
“prehaptens”	and	“prohaptens”‐	remains	an	interesting	challenge.	
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Summary 
This doctoral thesis aimed to describe the frequency of contact allergy to the fragrance-
allergy markers as tested in the baseline (standard) series, i.e. Fragrance Mix I (FM I), Fragrance Mix 
II (FM II), along with their individual components, and Myroxylon pereirae (MP) and colophonium, 
and, in addition, to determine trends in frequency of contact allergy over the years. We sought to 
characterize the age, sex, and lesion location of the fragrance-allergic patients and to study the 
association between the positive tests observed with the different fragrance-allergy markers.   
We also investigated whether the chemically modified oak moss absolute, treated by a 
polymer-based method and containing less amounts of the strongly sensitizing chloroatranol and 
atranol, still produced positive patch-test reactions in previously sensitized subjects.  
We also wanted to identify the nature of the fragrance allergens in topical pharmaceutical 
products in Belgium and particularly those that had caused iatrogenic allergic contact dermatitis 
(ACD), as well as those responsible for ACD from specific cosmetic products in the patient 
population investigated. 
In our studies, 6% to 9% of patients investigated for contact allergy reacted to the fragrance 
markers in the baseline series, with a fluctuating trend in frequency of positive reactions over the 
years. Our studies also showed that the majority of patients with fragrance sensitivity are women, 
which reflects a greater exposure to fragranced cosmetics in them.  
 The frequency of fragrance allergy gradually increased from young to adult age, the highest 
peak being between 20 and 40 years (40%) for females, and between 40 and 60 years (37.6%) for 
males, to decrease gradually again later on.  
 The hands and face were found to be the most commonly affected body sites, and significant 
associations between certain locations such as legs, arms, and axillae and specific fragrance 
allergens were observed; for example, a significant association was found between 
hydroxyisohexylcyclohexene carboxaldehyde (HICC) and axillae, at least in women. 
We also determined the frequency of positive reactions to the FM I and FM II individual 
components. Evernia prunastri was the most frequent FM I allergen, followed by isoeugenol, 
whereas HICC, and to a far less extend farnesol in FM II.  
Positive reactions to MP and FM I were frequently associated because of common 
components, i.e. eugenol, isoeugenol, cinnamal, and cinnamyl alcohol. The association between 
colophonium and FM I was partly due to the common presence of (oxidized) resin acids in Evernia 
prunastri, a FM I component, but together with MP also to (oxidized) terpenes, also present in 
essential oils and Compositae (Asteraceae) plants. 
With regard to trends in frequency of positive reactions over the years for the ingredients of 
the fragrance mixes, there was a slight increase for cinnamyl alcohol, which could be linked to its 
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relationship with ketoprofen photosensitization. For others, such as Evernia prunastri, HICC, and 
isoeugenol, a recent slightly descending trend was observed. This could be partially explained by 
concentration restrictions in their use (e.g. as for HICC and isoeugenol), fashion-related fragrance 
composition changes, and lastly by the requirement of labeling of the components on the cosmetic 
package, which perhaps also encourages the fragrance industry to omit the ingredients to be labeled. 
 Another objective of this thesis was to identify the nature of fragrance allergens in specific 
cosmetic products. Of the 30 causal fragrance allergens identified in this study, 18 had been 
required to be labeled since March 2005. In the 15 different categories of cosmetic products that 
were found to be responsible for allergic contact dermatitis, geraniol and HICC, as well as 
limonene, in particular, were the most frequent allergens for which their presence could be 
confirmed in the causal specific cosmetic products; moreover, hydroxycitronellal and Evernia 
prunastri were the most frequent fragrance allergens suspected to be present in such products. 
 The value of patch testing with allergens other than FM I, MP, and colophonium, such as FM 
II ingredients and limonene was also demonstrated: 40% of the reactions in 2009 were attributable 
to the latter allergens. In addition, some essential oils were responsible for reactions to several 
specific cosmetic products, lavender oil being the most frequent. The fragrance allergens identified 
in this study most often correlated with eau de toilette/fine perfumes and deodorants, which contain 
higher concentrations of fragrance chemicals, and in the latter case also in an occluded area, but 
also skin-care products were involved. Indeed, leave-on products are more likely to cause allergic 
contact dermatitis than rinse-off products, such as those used for cleansing. 
 Additionally, we determined which and how many topical pharmaceutical products contain 
fragrance components and examined their nature in products that played a role in iatrogenic ACD. 
Ten percent of topical pharmaceutical products in Belgium were found to contain 66 different 
fragrance components, among which products marketed several decades ago but also more recently 
introduced topical drugs such as non-steroidal anti-inflammatory drugs (NSAID’s). This 
predisposes the patients to develop multiple sensitivities and to react also to other fragrance-
containing products.  
 In summary, in this thesis various aspect of fragrance contact allergy have been studied, the 
results of which may contribute to a better understanding on fragrance allergy, in general. 
Furthermore, our studies showed that it is important to test not only with the baseline series or the 
ingredients of the fragrance mixes, but also with the fragrance-containing products and compounds 
that the patients actually come in contact with. 
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Samenvatting 
Dit doctoraal proefschrift heeft tot doel de frequentie van contactallergie voor 
parfumcomponenten, alsook trends in frequentie over de jaren heen, te onderzoeken. Dit gebeurde 
via analyse van patch-test resultaten bekomen met de parfummengsels, nl. “Fragrance Mix I” (FM 
I) en “Fragrance Mix II” (FM II), en hun respectievelijke inhoudsstoffen, en met Perubalsem 
(“Myroxylon pereirae”) (MP) en colofonium, welke indicatoren zijn voor parfumallergie en aldus in 
de standaardreeks ter diagnosestelling getest worden.  We karakteriseerden de leeftijd, het geslacht 
en de lokalisatie van de huidletsels van de parfum- allergische patiënten en bestudeerden 
geassocieerde positieve tests voor deze verschillende parfum-allergie markers.  
We onderzochten ook of de chemisch gewijzigde eik mos (“evernia prunastri”), behandeld 
door een polymeer gebaseerde methode waardoor de concentratie van de sterk allergene 
inhoudsstoffen chlooratranol en atranol gereduceerd werd, nog steeds positieve patch- test reacties 
veroorzaakten in vooraf gesensibiliseerde patiënten.  
We deden ook onderzoek naar de aard van de parfumallergenen in de in België op de markt 
gebrachte lokaal gebruikte farmaceutische producten, en in het bijzonder van deze die een rol 
hebben gespeeld in het veroorzaken van een iatrogeen-uitgelokte allergische contactdermatitis, 
alsook van deze die verantwoordelijk waren  voor allergische contactdermatitis uitgelokt door 
cosmetica. Onze studies wezen uit dat 6 % tot 9 % van de onderzochte patiënten een contactallergie 
vertoonden voor de parfumallergie merkers in de standaardreeks, en dit met een variërende 
frequentie van positieve reacties over de jaren heen. De meerderheid van de patiënten met 
parfumallergie waren vrouwen, wat een grotere blootstelling aan geparfumeerde cosmetica 
weerspiegelt.  
De frequentie van parfumallergie steeg geleidelijk aan van jonge tot volwassen leeftijd, met 
de hoogste piek tussen 20 en 40 jaar (40 % ) voor vrouwen en tussen de 40 en 60 jaar (37,6 % ) 
voor mannen, om geleidelijk weer af te nemen op latere leeftijd. 
De handen en het gelaat bleken de meest aangetaste lichaamsdelen te zijn, waarbij 
significante associaties tussen lokalisaties zoals benen, armen en oksels met specifieke 
parfumallergenen geobserveerd werden;  bijvoorbeeld een significant verband werd gevonden 
tussen oksels en hydroxyisohexylcyclohexeen carboxaldehyde (HICC), althans bij vrouwen. 
Wat de frequentie van positieve reacties op de individuele componenten van FM- I en II FM 
betreft: Evernia prunastri was het meest voorkomend FM I allergeen, gevolgd door isoeugenol, 
terwijl HICC en in veel mindere mate farnesol dit waren van FM II. 
Positieve reacties op MP en FM I werden vaak geassocieerd gezien vanwege 
gemeenschappelijke componenten, namelijk eugenol , isoeugenol, kaneelaldehyde (cinnamal) en 
kaneelalcohol (cinnamyl alcohol). De associatie tussen colofonium en FM I, met name Evernia 
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prunastri, wordt gedeeltelijk verklaard door de gemeenschappelijke aanwezigheid van 
(geoxideerde) harszuren, maar samen met MP ook door (geoxideerde) terpenen, tevens aanwezig in 
etherische oliën en Compositae (Asteraceae) planten. 
Wat de frequentie van positieve reacties over de jaren heen voor sommige bestanddelen van 
de parfummengsels betreft, was er een lichte stijging ,voor cinnamyl alcohol,  gekoppeld aan de 
relatie met ketoprofen fotosensibilisatie. Voor andere componenten, zoals Evernia prunastri, , 
HICC, en isoeugenol, werd recent een licht dalende trend waargenomen. Dit kan deels verklaard 
worden door reductie in gebruiksconcentratie (bijvoorbeeld voor HICC en isoeugenol), mode-
gerelateerde veranderingen in samenstelling van de parfum, en ten slotte door de vereiste  
etikettering van deze componenten op de cosmetische verpakkingen, dat wellicht de 
parfumindustrie stimuleert om deze ingrediënten uit de samenstelling weg te laten. 
Een ander doel van dit proefschrift was om de aard van allergene parfumcomponenten in 
specifieke cosmetische producten te identificeren. Van de 30 causale allergenen die in deze studie 
werden geïdentificeerd, waren er 18 die sinds maart 2005 dienden geëtiketteerd te worden. In de 15 
verschillende categorieën van de specifieke cosmetische producten verantwoordelijk voor 
allergische contactdermatitis waren geraniol en HICC, en vooral limoneen de meest 
voorkomendeallergenen en hydroxycitronellal en Evernia prunastri  de meest vermoedelijk 
aanwezige allergenen. Het nut van patch tests met andere allergenen dan FM I, MP en colofonium, 
zoals FM II ingrediënten en limoneen werd eveneens aangetoond: 40 % van de reacties in 2009 
konden aan deze allergenen worden toegeschreven. Bovendien waren ook sommige essentiële oliën 
verantwoordelijk voor reacties op diverse specifieke cosmetische producten, met lavendelolie als de 
meest voorkomende. De parfumallergenen waren in deze studie het meest gecorreleerd met 
toiletwaters/ “fijne” parfums en deodorantia, die hogere concentraties van geurstoffen bevatten, en 
in het laatste geval ook in een afgesloten gebied;, ook huidverzorgingsproducten (moisturizers ) 
waren betrokken. Inderdaad, zogenaamde “leave- on” producten (bedoeld om op de huid achter te 
blijven) geven meer kans op allergische huidreacties dan zogenaamde “rinse-off” producten die 
afgespoeld worden, zoals vb. huidreinigende middelen. 
Daarnaast gingen we ook na welke en hoeveel lokaal aangebrachte farmaceutische 
producten in België geurstoffen bevatten en welke allergenen een oorzaak waren geweest van 
iatrogeen uitgelokte allergische contactdermatitis. Tien procent van de topische geneesmiddelen in 
België, waaronder deze in de handel gebracht tientallen jaren geleden, maar ook meer recent 
geïntroduceerde producten zoals niet-steroïdale anti-inflammatoire geneesmiddelen bevatten maar 
liefst 66 verschillende parfumcomponenten. Dit beschikt de patiënten voor om meerdere 
sensibilisaties te ontwikkelen en ook te reageren op andere parfum- bevattende producten. 
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Samenvattend, in dit proefschrift werden verschillende aspecten van contactallergie voor 
parfumcomponenten bestudeerd, wat kan bijdragen tot een beter begrip van parfumallergie. Verder 
is uit onze studies gebleken dat het niet alleen belangrijk is om te testen met de parfum merkers uit 
de standaardreeks, maar ook  met de afzonderlijke bestanddelen van de parfummengsels, en niet in 
het minst met de parfum-bevattende producten en inhoudsstoffen waarmee de patiënten 
daadwerkelijk contact hebben. 
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